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Abstract
Mediation analysis hypothesizes that an exposure causes a mediator and in
turn the mediator causes the outcome, so mediation is inherently longitu-
dinal. Unfortunately, potential mediators may be measured with error and
regression estimators obtained by ignoring measurement error can be severely
biased. This can induce bias in the estimation of causal direct and indirect
effects. In Chapter 2, using regression calibration, we show how to adjust for
measurement error in longitudinal studies with repeated measurements of the
mediator, and evaluate the effect of ignoring measurement error on direct and
indirect effects. Rather than assuming normality for the random effects in the
linear mixed effects calibration model, we correct for measurement error in
the mediator allowing flexibility in the distribution of subject-specific random
effects. On the other hand, longitudinal studies face challenges of missing data
resulting from loss to follow-up, death, or withdrawal. In mediation analysis,
multiple imputation has been shown to perform well for data missing com-
pletely at random (MCAR) and missing at random (MAR) in cross-sectional
studies, but it is unclear how it performs in longitudinal studies under mis-
specification of the imputation model, specifically, where the misspecification
ignores clustering by subject. In Chapter 3, we examine the impact of ignoring
clustering on mediated effect estimates under MCAR and MAR mechanisms
with varying degrees of missingness. In Chapter 4, using data from a ran-
domized controlled trial, we examine the mediation effects on child neurode-
velopment of intermittent preventive malaria treatment in pregnant women.
Chapter 5 concludes and discusses future work.
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Chapter 1
Introduction
Many disciplines are interested in mediation, in which a third variable (medi-
ator) M partly describes the effect of an exposure X on an outcome Y (Figure
1.1). In a cross-sectional study, assume Xi is binary, and Mi and Yi are con-
Figure 1.1 Mediation directed acyclic graph (DAG).
tinuous variables for subject i. Direct and indirect (mediated) effects can be
parameterized using the linear models
E(Mi|Xi) = ζ0 + ζxXi, (1.1)
E(Yi|Xi,Mi) = γ0 + γxXi + γmMi. (1.2)
In the absence of an exposure-mediator interaction in model (1.2), the direct
effect is given by γx and the indirect effect by ζxγm. The direct effect measures
the exposure effect on the outcome after adjusting for the mediator while the
indirect effect measures the change in the outcome as a result of the exposure’s
effect on the mediator.
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Unfortunately, potential mediators may be measured with error and regres-
sion estimators obtained by ignoring measurement error can be severely bi-
ased (Valeri et al., 2014). This can induce bias in the estimators of causal
direct and indirect effects. Regression calibration is one method widely used
to correct for measurement error (Brown and Fuller, 1990; Carroll et al., 2006)
and may be useful when both the mediator and outcome are repeatedly mea-
sured. However, when the outcome is repeatedly measured, as is usually the
case in longitudinal studies, this method generally requires its user to assume
a distribution for the random effects and inferences may be sensitive to mis-
specification of this distribution.
In addition, longitudinal studies are prone to missing data due to missing
visits, withdrawals, lost to follow up or death. When the mediator or outcome
are missing, estimators can be biased and the missing data can also lead to
loss of information, decreased statistical power and weakened generalizability
of findings (Dong and Peng, 2013). Biased parameter estimators can induce
bias in the estimation of direct and indirect effects. In mediation analysis, the
mediator is both an outcome and a covariate, so any proposed method needs to
consider the mediator in both capacities. Multiple imputation (MI), a highly
recommended method for dealing with missing data, can be implemented in
current commercial software. However, all such software ignore correlation
among observations on the same unit (Mistler, 2013), which is characteristic
of longitudinal studies.
In Chapter 2, we describe the potential outcome framework for estimating
direct and indirect effects when the mediator is measured with error, and
propose a method to adjust for measurement error in a repeatedly measured
mediator. In Chapter 3, we examine the impact of ignoring clustering in MI
for longitudinal data on estimation of direct and indirect effects.
2
The methodological development in Chapters 2 and 3 is motivated by a prospec-
tive cohort study that examined the effects of cerebral malaria (CM), a severe
form of malaria, on neurodevelopment among chidren < 5 years. Malaria
is a disease caused mainly by Plasmodium falciparum or Plasmodium vivax
parasites. These parasites are spread from person to person through bites of
an infected female Anopheles mosquito. Globally, most malaria cases (90%)
and deaths (91%) occur in sub-Saharan Africa (WHO, 2017) and the groups
at most risk of malaria include infants, children under 5 years of age, and
pregnant women (Brabin, 1983; Rogerson et al., 2007). Pregnant women
are more susceptible to malaria infection than non-pregnant women (Bra-
bin, 1983; Rogerson et al., 2007). Malaria infection in pregnancy can lead
to placental malaria (PM) (Rogerson et al., 2007) and PM has been asso-
ciated with low birth weight and preterm birth (Desai et al., 2007; Kapisi
et al., 2017; Katz et al., 2013; Rogerson et al., 2007, 2003). Maternal im-
mune response and placental changes (Muehlenbachs et al., 2006) that occur
with malaria illness in pregnancy may interrupt maternal to fetus transfer
of nutrients, and this could adversely affect the developing fetal brain, and
lead to deficits in child neurodevelopment (ND). To protect pregnant women
against malaria and its effects on the unborn children, the World Health Orga-
nization (WHO) recommends intermittent preventive treatment in pregnancy
(IPTp) with sulfadoxine-pyrimethamine (SP) (WHO, 2017). However, some
studies in East Africa have shown a waning effect of SP (Bigira et al., 2014;
Iriemenam et al., 2012; Ndyomugyenyi et al., 2011) and proposed IPTp with
dihydroartenisinin-piperaquine (DP) (Nankabirwa et al., 2016, 2014; Tarning
et al., 2008). We hypothesize that the protective effect of IPTp with DP causes
placental changes that reduce effects of malaria in pregnancy such as placental
malaria, preterm birth, low birth weight, and low levels of hemoglobin lev-
els, thus improving ND in the offspring. Therefore, in Chapter 4, we analyze
data from a randomized controlled trial to estimate the mediated effects of
3
IPTp on child ND through maternal malaria, placental malaria, adverse birth
outcomes (preterm birth, low birth weight, and small for gestation age), cord
blood hemoglobin or child malaria.
4
Chapter 2
Mediation analysis for
longitudinal data using
regression calibration when the
mediator is measured with error
2.1 Introduction
In many disciplines, it is important to understand how the effect of an exposure
on an outcome is mediated through other variables. Unfortunately, potential
mediators may be measured with error. The influence of measurement error
in a continuous mediator on the total effects (direct and indirect effects) in
the context of generalized linear models has been studied previously (Valeri
et al., 2014). Since measurement error in the exposure variable (X), mediator
(M) and outcome (Y ) have different effects on estimates of the paths X → Y ,
X → M , and M → Y (Cole and Maxwell, 2003), regression estimators ob-
tained by ignoring measurement error can be severely biased and thus induce
bias in the estimation of causal and indirect effects (Valeri et al., 2014). How-
ever, much of the previous work concerning measurement error in mediation
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analysis has assumed that the mediator and outcome are collected at a single
time point.
A motivating example in this paper is a study among children of the effect
of cerebral malaria on cognitive development mediated by hemoglobin levels
(Cusick et al., 2016). Cerebral malaria (exposure) affects both hemoglobin
levels (mediator) and cognitive ability (outcome), and hemoglobin levels affect
cognitive ability in children (Boivin et al., 2016; John et al., 2008). In this
longitudinal study, hemoglobin and cognitive ability were repeatedly measured
over one year. To account for correlations among observations when there are
repeated measurements, a routine framework for longitudinal data analysis
is the linear mixed effects model (LMM). In mediation analysis, LMMs have
been found to perform well relative to structural equation models (SEMs), a
commonly used technique with continuous data (Blood et al., 2010), and are
robust to violations of the normality assumption for the errors (Blood and
Cheng, 2012). Even in the context of non-linear models, non-linear mixed
models (NLMMs) have been found to perform sufficiently well in the analysis
of mediated longitudinal binary data with respect to bias, coverage probability,
and power (Blood et al., 2010). Though LMMs can be applied in mediation
analysis for longitudinal data, the effect of a continuous mediator repeatedly
measured with error on the direct and indirect effects is not well understood.
Regression calibration is one method widely used to correct for measurement
error (Brown and Fuller, 1990; Carroll and Stefanski, 1990) and parametric
models are often assumed for the calibration model. However, parametric
assumptions about the distribution of random effects may be misleading in
some cases. Some studies have documented that fixed effect estimates can be
sensitive to misspecification of the random effects distribution (Agresti et al.,
2004; Heagerty and Kurland, 2001; Heckman and Singer, 1984), and this can
impact inference. Several methods have been proposed to allow flexibility in
6
the distribution of random effects including using a non-parametric maximum
likelihood approach that makes no distributional assumptions though the esti-
mated distribution of random effects is discrete (Aitkin, 1999) and requires a
significant computational burden to fit (Ghidey et al., 2004); a non-parametric
Bayesian approach which detects clusters with unusual results and avoids prob-
lems caused by masking in traditional parametric approaches (Burr and Doss,
2005; Ohlssen et al., 2007); a smooth non-parametric maximum likelihood ap-
proach involving a mixture of Gaussians which entails some computational
burden to fit (Magder and Zeger, 1996); a mixture of normals via the EM al-
gorithm (Verbeke and Lesaffre, 1996); and the skewed versions of the normal
and t-distributions, which have been recommended to assess the robustness of
conclusions (Lee and Thompson, 2008).
Blood and her collaborators focused on using LMMs to estimate direct and
indirect effects either when a binary exposure, mediator and outcome are all
time-varying (Blood and Cheng, 2011) or when a binary exposure and medi-
ator are only measured at baseline but the outcome is time-varying (Blood
et al., 2010), but did not consider that the mediator may be measured with
error. In this Chapter, we focus on estimating direct and indirect effects us-
ing LMM when a binary exposure is only measured at baseline with an error
prone time-varying mediator and a time-varying outcome. In Section 2.3, we
present a potential outcome framework for estimating the direct and time de-
pendent indirect effect in longitudinal studies when the mediator is repeatedly
measured without error. Prior to estimating direct and indirect effects, we
propose a method to adjust for measurement error in a repeatedly measured
mediator using regression calibration. Rather than assuming normality for
the random effects in the calibration model, we correct for measurement er-
ror in the mediator allowing flexibility in the distribution of random effects.
We assume the random effects density belongs to a class of smooth densities
(Gallant and Nychka, 1987) and use a seminonparametric (SNP) linear mixed
7
model described by Zhang and Davidian (2001) and Chen et al. (2002) briefly
outlined in Section 2.5. We use a simulation study to compare the performance
of our method to an ad hoc approach that ignores possible measurement er-
ror on estimators of the direct and indirect effects. We apply the method to
a study in which hemoglobin level mediates the effect of cerebral malaria on
child cognition and an HIV study where ART adherence mediates the effect
of heavy alcohol use and HIV progression, and conclude this Chapter with a
discussion in Section 2.8.
2.2 Methods
2.3 Mediation analysis with linear mixed mod-
els without measurement error in the me-
diator
Let Yij, Xij, Gi, and Cij denote the observed outcome, exposure, baseline co-
variate, and mediator-outcome confounder respectively for subject i at time
j = 1, . . . , s. Let Mij be the mediator measured with error while M
∗
ij is the
mediator without error for subject i at time j. Since a subject’s exposure sta-
tus does not change in studies that motivate this work, Xij is constant within
subject i from time 0 through s, though in other studies it can be time-varying.
We therefore subsequently drop j on Xij to reflect a non time-varying expo-
sure, Xi for subject i.
We present a directed acyclic graph (DAG) for two time points in Figure
2.1 to illustrate assumptions about mediators measured with error relative
to those without error, and relationships among other variables. Bind et al.
(2015) considered a time-varying exposure that directly affected the mediator
and outcome at only the same time point. In this setup (Figure 2.1), the non
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time-varying exposure (Xi) affects the mediator and outcome at baseline and
subsequent time points. Using the potential outcome framework for longitudi-
Figure 2.1 Directed acyclic graph (DAG) for time points j = 1, 2. Mi1 and
Mi2 are mediators measured with error while M
∗
i1 and M
∗
i2 are without error.
nal data described by van der Laan and Petersen (2004), VanderWeele (2010)
and Bind et al. (2015), let Yij(xi,m
∗
ij) denote the counter factual outcome for
subject i at time j when Xi was set to xi and M
∗
ij was set to m
∗
ij and let
M∗ij(xi) be the counter factual mediator for subject i at time j when their ex-
posure status was set to xi. For consistency, we assume that M
∗
ij(Xi) = M
∗
ij,
and Yij(Xi,M
∗
ij) = Yij (Cole and Frangakis, 2009; VanderWeele, 2009). Bind
et al. achieved identifiability of mediation effects in a longitudinal design by
conditioning on the random effects (Bind et al., 2015). A difference between
the current study and Bind et al. (2015)’s study is that in the latter the medi-
ator is measured without error. The following identification assumptions are
needed to estimate mediation effects
(1) Yij(xi,m
∗
ij) ⊥ Xi|Gi = gi,
(2) M∗ij(xi) ⊥ Xi|Gi = gi,
(3) Yij(xi,m
∗
ij) ⊥ M∗ij|Xi = xi, Gi = gi, Cij = cij,
(4) Yij(xi,m
∗
ij) ⊥ M∗ij(x′i)|Gi = gi, Cij = cij.
These assumptions hold if there is no unmeasured exposure-outcome confound-
ing, no unmeasured exposure-mediator confounding, no unmeasured mediator-
outcome confounding, and no unmeasured mediator-outcome confounder af-
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fected by the exposure, for assumptions (1)−(4) respectively. Assumptions (1)
and (2) are automatically satisfied if the exposure is randomized. Assuming
no time-varying confounding with respect to M∗ij and time-varying covariates
(VanderWeele and Tchetgen Tchetgen, 2017), we then define the average direct
effect at time j as
ADEj = E
[
E
{
Yj(1,M
∗
j (x))− Yj(0,M∗j (x)) | Gi = gi, Cij = cij, tj
}]
and the average causal mediation effect
ACMEj = E
[
E
{
Yj(x,M
∗
j (1))− Yj(x,M∗j (0)) | Gi = gi, Cij = cij, tj
}]
for some x. With an exposure-time interaction in the mediator model, we note
that the mediation effects can change over the course of the study.
In this longitudinal context, to estimate the time-varying average causal me-
diation effect (ACME) or indirect effect, two regression models would be fitted
if we could observe the mediator without error. The first regression model,
referred to as the outcome model, is the regression of the outcome Yij on the
exposure Xi, mediator M
∗
ij, exposure-mediator interaction, covariate Gi, and
confounder Cij.
E(Yij|Xi,M∗ij, Gi, Cij, bYi , tj) = γ0 + γxXi + γmM∗ij + γxmXiM∗ij + γt2t2 + . . .
+ γtsts + γgGi + γcCij + b
Y
i (2.1)
where tj is the time indicator such that tj = I(t = j), b
Y
i is the subject specific
random effect in the outcome model and is assumed to be normally distributed,
i.e., bYi ∼ Normal{0, σ2bY }. The effect of the exposure Xi on the outcome Yij
estimated by γx + γxmm
∗
ij is the average direct effect (ADE) or direct effect
(Baron and Kenny, 1986; Valeri et al., 2014).
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The second regression model, referred to as the mediator model, is the regres-
sion of the mediator Mij on the exposure Xi, with an exposure-time interaction
and covariates Gi.
Mij = ζ0+ζxXi+ζt′2t2+· · ·+ζt′sts+ζt2Xit2+· · ·+ζtsXits+ζgGi+bMi +Mij (2.2)
where bMi is a subject specific random effect. We typically assume that b
M
i ∼
Normal{0, σ2bM}, and the short term biological variability and measurement
error in the mediator Mij ∼ Normal{0, σ2M} independently of bMi . Random
effects bYi and b
M
i are assumed to be independent.
Using the product method (Baron and Kenny, 1986) and with some alge-
bra, the time dependent ACMEj or time dependent indirect effect is then
estimated as (also see appendix A.1 for details);
ACMEj = E
{
Yj(x
′,M∗j (x))− Yj(x′,M∗j (x˜)) | Gi = gi, Cij = cij, tj
}
= γm
{
ζx + ζtj
}
(x− x˜) + γxmx′
{
ζx + ζtj
}
(x− x˜)
where x = 1, x˜ = 0 and x′ can be 0 or 1. Since the exposure coefficient in the
mediator model is fixed within subject, we do not add the covariance of the
coefficients as proposed by previous studies (Bauer et al., 2006). This has also
been documented in the context of linear regression (VanderWeele, 2016).
In the absence of exposure-mediator interaction in the outcome model, the
ACMEj reduces to γmζx+γmζtj , and in the absence of interaction in both mod-
els (2.1) and (2.2), the ACME reduces to γmζx, which is not time-dependent.
Mediation effects in longitudinal studies have also been defined where there are
multiple time-varying mediators, random slopes, interactions between multi-
ple mediators, and when the random effects are correlated (Bind et al., 2015).
The sampling distribution of the mediated effect or the ACME is not always
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well-approximated by a normal distribution (MacKinnon et al., 2004), thus
confidence limits based on the normal distribution for the mediated effect
are often inaccurate (MacKinnon et al., 2002, 1995). Therefore, resampling
methods and methods based on the sampling distribution of γmζx have been
recommended for better ACME coverage (MacKinnon et al., 2004).
2.4 Regression calibration when the mediator
is measured with error
When the mediator is measured with error, we do not get to observe the true
mediator M∗ij (without error), but instead observe Mij = M
∗
ij + 
M
ij , where 
M
ij
is the measurement error. However, because we collect data longitudinally,
we can use regression calibration to obtain consistent estimators for linear
mixed model coefficients (Buonaccorsi et al., 2000; Carroll et al., 2006) without
access to a separate validation data set. Assuming the classical measurement
error model holds, then equation (2.2) gives the regression calibration model.
The random effect associated with the mediator calibration model bMi can be
assumed to be normally distributed or assumed to take a seminonparametric
form described in Section 2.5. Allowing flexibility in the distribution of random
effects, the calibrated mediator becomes
M̂∗ij = E(Mij|Xi, tj, Gi, bˆMi ) = ζˆ0 + ζˆxXi + ζˆt′2t2 + · · ·+ ζˆt′sts + ζˆt2Xit2 + . . .
+ ζˆtsXits + ζˆgGi + bˆ
M
i (2.3)
where bˆMi is the estimated best linear unbiased predictor (BLUP). We then
use M̂∗ij from model 2.3 in model 2.1 in the place of the unobserved M
∗
ij and
proceed to estimate the ADE and ACME as described in section 2.3. Regres-
sion calibration (RC) in linear mixed models for longitudinal studies has been
documented by Buonaccorsi et al. (2000). They show that under the classical
measurement error model, the mediator model (2.2), and the outcome model
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(2.1), RC estimators are equivalent to pseudo-maximum likelihood estimators
under normality if the random effects design matrices in models (2.1) and
(2.2) are the same. Though Wang et al. (1999) show that RC estimates in
generalized linear mixed measurement error models may result in inconsistent
estimators, Buonaccorsi et al. (2000) show that RC estimators are consistent
and that RC is highly efficient for estimation of fixed effects in linear mixed
models.
2.5 Seminonparametric linear mixed model
Of course, the consistency of regression parameter estimators in the outcome
model depends on making the correct assumption about the random effects in
the regression calibration model. The seminonparametric (SNP) linear mixed
model has been described by Zhang and Davidian (2001). In this framework,
the subject specific random effects are represented as
bMi = µ+RZi (2.4)
where µ is a (q×1) vector of parameters, R is a (q×q) lower-triangular square
matrix and Zi is a (q×1) random vector. Usually, Zi is assumed to be standard
multivariate normal, so that bMi ∼ Nq(µ,RRT ). Instead, Zi and hence bMi is
assumed to belong to a class of smooth densities (Gallant and Nychka, 1987)
without unusual behavior such as kinks, jumps or oscillations that would be
unrepresentative of the expected subject-to-subject heterogeneity. However,
these densities are sufficiently differentiable and can be skewed, multimodal, or
fat- or thin-tailed relative to the normal. Zhang and Davidian (2001) represent
the density of Zi by a standard SNP density
hK(z) = P
2
K(z)ϕ(z) =
{ ∑
|λ|≤K
aλz
λ
}2
ϕ(z)
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where λ = (λ1, · · · , λq) is a vector of nonnegative integers, q is the dimension
of the random effects, zλ is the monomial zλ = zλ11 · · · zλqq of order |λ| =∑q
k=1 λk, ϕ(z) is a q-dimensional standard normal density, K is the order of
the polynomial acting as a tuning parameter controlling the degree of flexibility
of the resulting density hK(z), and the coefficients aλ of PK(z) are chosen such
that
∫
hK(z)dz = 1. They ensure
∫
hK(z)dz = 1 by imposing E{P 2K(U)} = 1,
where U ∼ Nq(0, I). When K = 0, PK(z) ≡ 1 and model (2.2) reduces to
the usual linear mixed model with bMi ∼ Nq(µ,RRT ). This normal density
modified by a squared polynomial (i.e. k = 2) can approximate complicated
shapes such as skewed or multimodal distributions. For the parameter space
ζ = {ζ0, ζx, . . . , ζg} in model (2.2), an empirical Bayes approach is then used
for inference on individual bMi by finding the maximizer Zˆi of the posterior
density f(Zi|Mi; ζ) ∝ f(Mi|Zi; ζ)P 2K(Zi)ϕ(Zi) with ζ = ζˆ and calculating
bˆi = µˆ+ RˆZˆi (Zhang and Davidian, 2001).
2.6 Data application examples
We apply regression calibration to two data sets and estimate both the ADE
and time-varying ACME with their respective confidence intervals. First, we
assume the random effects in the mediator model are normally distributed,
and second, allow flexibility in the distribution of random effects using the
SNP approach. We also present results when no regression calibration is used,
in other words, when the mediator is measured with error (Table 2.1) and this
is not handled by the analysis.
2.6.1 Severe malaria and cognition data
We consider a longitudinal study conducted in Uganda, one objective of which
was to elucidate the contributions of iron deficiency and malaria to neurocog-
nitive impairment. In this prospective cohort study, children under 5 years of
age with cerebral malaria (CM) and community control (CC) children were
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tested for cognitive development at baseline, 6 months and 12 months using
the Mullen scales of early learning that includes five subscales (gross motor,
visual reception, fine motor, expressive language, and receptive language). A
Mullen composite was generated by summing up four subscales excluding gross
motor. Cerebral malaria, a form of severe malaria, may indirectly affect levels
of hemoglobin (hgb) in children while directly affecting their neuro-cognitive
development. Hemoglobin, presumed to be measured with error, mediates the
association between severe malaria and neuro-cognition (Boivin et al., 2016).
In this setting, we have a mediator (hemoglobin) measured at baseline, 6
months and 12 months. Covariates included study group (CM=1, CC=0),
any child education (Educ), and age. The calibration model was given by
Hgbij = ζ0 + ζ1Groupi + ζ2I(t = 6) + ζ3I(t = 12) + ζ4Groupi ∗ I(t = 6)
+ ζ5Groupi ∗ I(t = 12) + ζ6Educi + bM0i + Mij
where Hgbij is the hemoglobin measurement for child i at time j = 0, 6, 12
months, t is the time indicator, and the Mij are assumed to have a normal
distribution N(0, σ2M ). The calibrated hemoglobin is then estimated, first as-
suming bM0i , the subject-specific random intercept, is normally distributed and
secondly assuming it belongs to a class of SNP densities (Gallant and Nychka,
1987; Zhang and Davidian, 2001).
To compute the average causal mediation effect (ACME) and average direct
effect (ADE), the outcome model was
Yij = γ0 + γ1Groupi + γ2Hgb
∗
ij + γ3I(t = 6) + γ4I(t = 12) + γ5Ageij
+ γ6Educi + b
Y
0i + 
Y
ij
where Yij is the Mullen composite score measurement for child i at time j,
Hbg∗ij is the true hemoglobin value for child i at time t, b
Y
0i is the random in-
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tercept and Yij is the random error. The interaction between study group and
hemoglobin was not significant, and thus excluded from the outcome model.
Since Hbg∗ij is unknown, we use the regression calibration estimate Ĥbg
∗
ij de-
scribed earlier. Identification assumptions were examined prior to estimating
the mediation effects (appendix A.2.1). In the presence of interaction between
study group and time in the mediator model, the ACME was given by γ2ζ1 at
baseline, γ2(ζ1 + ζ4) at 6 months, and γ2(ζ1 + ζ5) at 12 months. For the SNP
calibration model, K = 1 was selected using AIC. Table 2.1 presents results
for the ACME and ADE and their respective 95% confidence intervals for the
malaria-cognition data.
Table 2.1 ACME and ADE estimates for the
malaria-cognition data when the mediator is uncalibrated or
calibrated assuming normality or SNP for the random effects.
Time point Calibration Average causal mediation effect (ACME)
Estimate LP UP
Baseline Normal -1.407 -5.694 2.684
SNP -2.099 -4.639 0.265
Uncalibrated -2.257 -5.302 0.794
6 months Normal -0.012 -0.337 0.162
SNP -0.018 -0.258 0.206
Uncalibrated -0.019 -0.339 0.183
12 months Normal 0.027 -0.158 0.287
SNP 0.040 -0.122 0.253
Uncalibrated 0.043 -0.139 0.318
Average direct effect (ADE)
Estimate LP UP
Normal -9.178 -14.540 -4.356
SNP -9.853 -16.441 -4.009
Uncalibrated -8.801 -14.293 -3.851
LP, Lower 0.025 bootstrap percentile; UP, Upper 0.975 bootstrap
percentile; SNP, Seminonparametric approach. Number of
bootstrap data sets for percentile confidence intervals = 2000.
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Results from Table 2.1 suggest that mediation effects (ACME and ADE) fol-
lowing regression calibration assuming normality for the individual specific
random effects gives results not very different from when there is flexibility
in the distribution of the same random effects. For example, the ACME at
baseline assuming normality for the random effects was -1.407 (95% CI -5.694,
2.684) compared to -2.099 (95% CI -4.639, 0.265) for the SNP approach. No
calibration on the other hand gave ACME estimates (baseline ACME = -2.257,
95% CI -5.302, 0.794) closer to those for SNP calibration than for normal cal-
ibration, although this was not the case for ADE. However, examining the
95% CI for ACME at baseline, 6 months and 12 months for normal, SNP and
uncalibrated mediators, they are all similar.
2.6.2 HIV-LIVE (Longitudinal Interrelationships of
Viruses and Ethanol) data
We consider a prospective cohort study in the United States of 400 HIV-
infected patients with a history of alcohol problems. This study investigated
the relationship between alcohol and HIV disease progression and related fac-
tors. Heavy alcohol consumption can affect a patient’s ability to adhere to
medication, and this in turn can worsen HIV disease progression. Previous
analyses have demonstrated (1) a significant effect of heavy alcohol consump-
tion on CD4 cell count (Samet et al., 2007), (2) an association between any
alcohol use and worse ART adherence (Samet et al., 2004) and (3) a reduction
in the effect of heavy alcohol consumption on CD4 cell count after control-
ling for medication adherence among patients on antiretroviral therapy (ART)
(Samet et al., 2007), suggesting that medication adherence could mediate the
effect of heavy alcohol consumption on the CD4 cell count. Data was collected
every 6 months from baseline to 42 months. Three-day adherence to ART was
determined using the AIDS Clinical Trials Group Questionnaire for Adherence
to Antiretroviral Medications and heavy alcohol use termed ‘at-risk of drink-
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ing’, was evaluated according to the National Institute of Alcohol Abuse and
Alcoholism (NIAAA) guidelines. Other variables included CD4 cell count, age,
literacy score, homeless in last 6 months (yes/no), and HIV Quality of life scale
(HIV QOL). CD4 cell counts were skewed and so a square root transformation
was performed before analysis. Three quarters (75%) of the study participants
were male, mean age was 42.5 years (Standard deviation = 7.4) and 125 (31%)
were ‘at-risk of drinking’ at baseline (Alc). The mediator calibration model
was
Adherenceij = β0 + β1Alci + β2Age BLi + β3HIV QOLij + β4Literacyi
+ β5I(Time = 2) + · · ·+ β11I(Time = 8)
+ β12I(Time = 2) ∗ Alc+ · · ·+ β18I(Time = 8) ∗ Alc
+ bM0i + 
M
ij .
For SNP calibration, different K values were evaluated. K = 2 gave the smallest
Akaike’s Information Criterion (AIC) and thus was fixed at that value. The
outcome model was
sqrt CD4ij = θ0 + θ1Alci + θ2 ̂Adherence
∗
ij + θ3Age BLi + θ4HIV QOLij
+ θ5Homelessij + θ6I(Time = 2) + · · ·+ θ12I(Time = 8)
+ bY0i + 
Y
ij
where ̂Adherence
∗
ij is the calibrated adherence. The interaction between at
risk of drinking and adherence was not significant. Appendix A.2.2 presents
an examination of identification assumptions. The average direct effect of
heavy alcohol consumption after controlling for adherence and other covariates
were -1.901 (95% CI -3.340, -0.309) assuming normal random effects for the
calibration model, -1.903 (95% CI -3.326, -0.318) assuming the SNP approach,
and -2.058 (95% CI -3.477, -0.568) for the uncalibrated mediator. Since the
mediator model included an interaction between heavy alcohol use and time,
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the ACME at baseline was given by θ2β1, and at time j = 2, . . . , 8 was given
by θ2β1 + θ2β1j, taking on different values at different time points. ACME
estimates with their corresponding bootstrap confidence intervals are displayed
in Figure 1. We see similar ACME estimates for normal calibration and SNP
calibration at all 8 time points. When no calibration is conducted, the ACME
estimates at all time points are close to zero and the confidence intervals are
much smaller.
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Figure 2.2 ACME estimates with respective bootstrap confidence intervals
for HIV-LIVE data by time points either assuming normality or SNP approach
for the random effects in the mediator calibration model.
2.7 Simulation study
We conducted a simulation study to investigate how measurement error in
the mediator affects ADE and ACME. The residual errors in the mediator
and the outcome models were independent. A sample of i = 1, · · · ,m = 600
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subjects, each with j = 1, · · · , 6 observations, was generated. The mediator
data-generating model was
Mij = ζ0 + ζ1Xi + ζ2I(j = 2) + · · ·+ ζ6I(j = 6) + bM0i + Mij
where xi is the exposure indicator (50% exposed and the rest non-exposed),
I is an indicator function allowing differing values of the continuous mediator
and outcome within individual at different time points, ζ0 = 4, ζ1 = −1.7,
ζ2 = 3.3, ζ3 = 3.8, ζ4 = 4.3, ζ5 = 4.8, ζ6 = 5.3; Mij and the subject specific
random intercept bM0i are independent. To examine the benefit of allowing
flexibility in the distribution of random effects in the mediator model versus
assuming normality, bM0i were simulated under three distributions scenarios,
taking on a
i. Normal distribution, N(0, 4)
ii. Chi-square distribution, χ2(4).
iii. Mixture of normals distribution, 0.65N(0, 1) + 0.35N(4, 1)
To obtain the calibrated mediator, separate models were fit where bM0i was first
assumed normally distributed, and secondly, assumed to come from a class
of smooth densities (SNP). For the SNP approach, K was chosen using the
Akaike’s Information Criteria (AIC) after fitting three models with K = 0, 1,
or 2. The K from a model with the least AIC was chosen. The outcome
data-generating model was
Yij = γ0 + γ1Xi + γ2M
∗
ij + γ3I(j = 2) + · · ·+ γ7I(j = 6) + bY0i + Yij
where xi, and I are as described before, γ0 = −1.0, γ1 = −0.6, γ2 = 0.8,
γ3 = 0.15, γ4 = 0.25, γ5 = 0.4, γ6 = 0.55, γ7 = 0.7; Yij and Mij were
from a multivariate normal distribution, with means zero, V ar(Yij) = 1,
V ar(Mij) = 1.5, and Cov(Yij , Mij) = 0.
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2000 data sets were generated under each distribution scenario for Mij. The
calibrated mediator M̂∗ij was computed for each data set, first, assuming b
M
0i are
normally distributed, and second, assuming they come from a class of smooth
densities. The computed ADE and ACME under each assumption for bM0i was
compared to true estimates (ACME = -1.360, ADE = -0.60) (Table 2.2). We
computed the mean square error (MSE) between the predicted random effects
and the simulated random effects under both the normality assumption and
the SNP approach (see Table 2.3). All simulations were conducted in SAS
version 9.4.
Without mediator calibration, both ACME and ADE estimators were biased
for all mediator random effects distributions used to generate the data. In par-
ticular the ACME was over estimated while the ADE was under estimated.
Under these simulation assumptions, we note that the ACME was biased to-
wards the null while the ADE was biased away from the null. However, results
improved substantially using regression calibration. ACME and ADE esti-
mators assuming a normal calibration model were approximately unbiased
irrespective of the random effects distribution used to generate the data. This
was also the case when the SNP approach was used for the calibration model.
Assuming normality for the calibration model, irrespective of random effects
distribution, gave similar results (both ACME and ADE estimates) to allowing
flexibility in the random effects distribution using the SNP approach. Further
simulations comparing the mean square error (MSE) for the true random ef-
fects and the estimated random effects showed that the random effects mean
square errors when normality was assumed for the calibration model were very
similar to those when flexibility of the random effects distribution was assumed
using the SNP approach. On the other hand, without calibration, the ACME
estimator at baseline was away from the null for the severe malaria and cog-
nition data whereas the ADE was towards the null compared to normal and
SNP calibration results. This suggests that no calibration for a mediator mea-
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sured with error could bias mediation effects in any direction of the null. This
simulation included six time points; we also conducted simulations with only
three time points and results were similar (appendix tables A.1 and A.2).
Table 2.2 Simulation results: average causal mediation effect (ACME) and
average direct effect (ADE) estimates either assuming normality or SNP ap-
proach for the random effects in the mediator calibration model.
Average causal mediation effect (ACME)
Distribution of RE Normal calibration model SNP calibration model Using mediator with error
Estimate Bias MSE Estimate Bias MSE Estimate Bias MSE
(-1.360) (-1.360) (-1.360)
Normal -1.364 -0.004 0.020 -1.364 -0.004 0.020 -0.207 1.153 1.330
χ2(4) -1.362 -0.002 0.037 -1.362 -0.002 0.037 -0.269 1.091 1.194
Mixture of Normals -1.358 0.002 0.023 -1.360 -0.000 0.023 -0.220 1.140 1.301
Average direct effect (ADE)
Estimate Bias MSE Estimate Bias MSE Estimate Bias MSE
(-0.600) (-0.600) (-0.600)
Normal -0.600 0.000 0.011 -0.600 0.000 0.011 -1.757 -1.157 1.358
χ2(4) -0.600 0.000 0.010 -0.600 0.000 0.010 -1.694 -1.094 1.227
Mixture of Normals -0.601 -0.001 0.010 -0.599 0.001 0.010 -1.739 -1.139 1.320
RE, Random effects; MSE, Mean square error; SNP, Seminonparametric
approach. Number of Monte-Carlo data sets = 2000.
Table 2.3 Simulation results: mean square errors and standard deviation
comparing true random effects distribution and estimated random effects dis-
tribution assuming normality or using the SNP approach.
Distribution of Random effects Normal χ24 Mixture of Normals
MSE SD MSE SD MSE SD
Normal calibration 0.248 0.019 0.268 0.030 0.252 0.021
SNP calibration 0.250 0.024 0.261 0.033 0.242 0.019
RE, Random effects; MSE, Mean square error; SD, Standard deviation. The
mediator and outcome are independent. Number of Monte-Carlo data sets =
2000.
2.8 Discussion
We have studied how measurement error in the mediator affects estimators
of the direct and indirect effects. Rather than assuming normality for the
random effects in the mediator calibration model, we allowed flexibility in the
distribution of random effects and evaluated its impact on direct and indirect
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effect estimators.
Estimation of the average causal mediation effect depends on estimates of the
effect of the exposure on the mediator and the effect of the mediator on the
outcome. Thus, any bias in these two estimators is carried forward to estima-
tion of the ACME. Measurement error in the mediator which is not accounted
for in the analysis, leads to biased parameter estimators in the outcome model
and biases estimators of the causal effect. However, when the mediator is col-
lected longitudinally, as is done in many studies, regression calibration may
be used to obtain improved estimators of the causal effect without the need
for an external validation dataset. A key finding in our study is that misspec-
ifying the random effect distribution in the mediator calibration model had
no impact on the ACME estimates for the cases considered. That is, when
the random effects distribution deviates from normality such as chi-square
(skewed) or mixture of normals, our results suggest that assuming normal-
ity for the mediator calibration still gives approximately unbiased estimators
of the ACME and ADE, an indication of robustness. We used the seminon-
parametric approach (SNP) to allow flexibility in the distribution of random
effects; other methods could be used.
Dividing the calibration mediator in model (2.3) into three components, i.e.,
fixed effects, intercept and random effects, potential biases during regression
calibration are likely to emerge from three sources: (1) estimation of the fixed
effects, (2) estimation of the intercept, and (3) estimation of the random ef-
fects. Though previous studies show mixed results on how misspecification of
the random effects distribution affects the estimation of fixed effects (Agresti
et al., 2004), several studies have documented that fixed effect estimators are
approximately unbiased (McCulloch and Neuhaus, 2011; Neuhaus et al., 1992).
The continuous mediator in our setting is a within-cluster covariate, which
means that it varies within cluster but has a constant average between clus-
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ters (McCulloch and Neuhaus, 2011). Studies have shown little impact of
random effects distribution misspecification on the estimation of the effect
of a within-cluster covariate (McCulloch and Neuhaus, 2011; Neuhaus et al.,
1992; Zhang and Davidian, 2001). It follows, therefore, that the effect of the
calibrated mediator on the outcome will be unbiased whether we allow flexi-
bility in the distribution of random effects in the calibration model or make
the common normality assumption. The estimation of the intercept also af-
fects the calibrated mediator. Neuhaus et al. (1992) showed that estimates
of the intercept for nonlinear models may be biased when the random effects
distribution is far from normal, however, this is not the case for linear mixed
models (McCulloch and Neuhaus, 2011). Our simulation results are consistent
with findings by McCulloch and Neuhaus (2011), i.e. that assuming normality
for the random effect distribution for the mediator model has little or no effect
on the estimation of the intercept.
Another source of bias is the prediction of the random effects. This study
compared predicted random effects for the mediator model assuming normal-
ity versus predicted random effects assuming the SNP approach. The SNP
approach had similar mean square error compared to assuming normality for
the different random effects distribution assumptions. These results are consis-
tent with other studies that found no change (Magder and Zeger, 1996) or not
very large differences (Agresti et al., 2004) in the estimation of random effects
when the assumed random effects distribution was not normal yet normality
was assumed. Agresti et al. (2004) studied effects of assuming normality for
the random effects for binary response data and their approach did not per-
form well when the true distribution was a two-point mixture with a large
variance component, which is unrealistically extreme. In the study by Magder
and Zeger (1996), they found that allowing flexibility in the distribution of ran-
dom effects using the nonparametric maximum likelihood estimate (NPMLE)
and the smooth nonparametric maximum likelihood estimate (SNPMLE) when
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the true distribution was Gaussian, skewed or discrete, yielded similar mean
square errors for the random effects compared to assuming normality. The
current study results bolster the notion that assuming normality for the dis-
tribution of random effects when they are non-normal has little or no impact
on predicted random effects.
Our simulations included only random intercept models. McCulloch and
Neuhaus (2011) points out that when the mean of the random effects dis-
tribution depends on a covariate, a relationship between the covariate and the
random effect distribution is introduced, creating a serious bias in estimating
the relationship between the covariate and the outcome. We did not examine
this scenario, and the potential effects of this relationship on the estimation
of ACME and ADE need to be investigated further.
A strong assumption in our study was that the residual error in the medi-
ator and outcome models were uncorrelated. In appendix A.4, we show that
as the mediator-outcome correlation increases, with an increase in within sub-
ject variability, the ACME and ADE estimates are more biased. More research
towards bias correction in estimates is needed, especially when mediator and
outcome are correlated.
We have documented a method to calibrate an error prone repeatedly mea-
sured mediator in mediation analysis for longitudinal data. In the presence of
measurement error in the mediator, regression calibration improves mediation
effect estimates compared to no calibration at all.
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Chapter 3
Missing data and mediation
analysis in longitudinal studies
3.1 Introduction
Longitudinal studies, even those that are well designed and executed, face
challenges of missing data that often result from loss to follow-up, death, or
withdrawal. Missing data can lead to biased estimators, loss of information,
decreased statistical power and weakened generalizability of study findings
(Dong and Peng, 2013). Patterns of missing data are classified as missing
completely at random (MCAR), where the probability of missingness does not
depend on observed or unobserved data; missing at random (MAR), where
the probability of missingness depends on the observed data but not on the
unobserved data; and missing not-at-random (MNAR), where the probability
of missingness depends on the unobserved data (Little and Rubin, 1987; Ru-
bin, 1976). Methods proposed to deal with missing data include complete case
analysis, pairwise deletion, mean substitution, which are older methods that
are highly discouraged, and popular contemporary methods such as multiple
imputation (MI) and maximum likelihood (ML) methods (Graham, 2009). MI
and ML methods are often used because they preserve data characteristics, re-
sult in parameter estimators that are unbiased (Graham, 2009; Schafer and
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Graham, 2002) when data is MCAR or MAR, and can be implemented in
commercially available software such as PROC MI in SAS or MI IMPUTE in
STATA. MI is preferred to ML methods in some situations because it creates
complete data sets (which allow use of statistical methods that work only with
complete data (Schafer, 2001; Wu and Jia, 2013)), allows for missing values
in the predictors, separates the imputation phase from the analysis phase (al-
lowing variables that explain nonresponse, but are not of interest in analysis,
to be used in the imputation phase (Schafer, 2001)), and allows the use of
different models for analysis and imputation.
Mediation analysis hypothesizes that the exposure causes the mediator and in
turn the mediator causes the outcome (MacKinnon, 2008; MacKinnon et al.,
2007), so that mediation is inherently longitudinal. In mediation analysis, MI
has been shown to perform well for cross-sectional data for both MCAR and
MAR data with and without auxiliary variables (Wu and Jia, 2013; Zhang
et al., 2015), but, it is unclear how MI performs in longitudinal studies when
researchers are interested in delayed mediated effects. An example is a study of
children under 5 years (Cusick et al., 2016) that examined the effect of cerebral
malaria on cognitive development, mediated by hemoglobin level. Researchers
may be interested in the mediated effects of (i) baseline hemoglobin, and (ii)
change in hemoglobin level from baseline to 6 months or to 12 months, on the
effect of cerebral malaria on cognitive development at 12 months or on the
change in cognitive development from baseline to 12 months.
MI in current commercial software typically ignores correlation among obser-
vations on the same unit or cluster (Mistler, 2013), which is characteristic of
longitudinal studies. In cluster randomized trials (CRTs), ignoring correlation
among observations has been found to bias cluster means towards the grand
mean and to underestimate between-cluster variance (Taljaard et al., 2008;
Zhou et al., 2014). Using MI in these commercial software packages with-
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out modification can bias fixed effects estimators in CRTs (Andridge, 2011;
Black et al., 2011). To our knowledge, no one has examined the impact of ig-
noring clustering in the imputation model on mediated effects in longitudinal
studies. To preserve the hierarchical structure of data during imputation in
CRTs, Graham (2009) proposed to include a cluster-specific dummy variable
as a fixed effect in the imputation model. However, CRTs have a few large
clusters, while longitudinal studies, where study participants are treated as
clusters, have moderate to large number of clusters. Moreover, including clus-
ter dummy variables makes imputed values biased towards the cluster means
and this inflates differences between clusters (Zhou et al., 2014). Previously,
studies that compared ignoring versus considering clustering in imputation
models have been in CRTs (Andridge, 2011; Black et al., 2011; Taljaard et al.,
2008; Yucel and Demirtas, 2010) and not in longitudinal studies. Furthermore,
these studies have examined the effect of ignoring clustering on fixed effects
without mediation. In the context of mediation analysis, the mediator is both
an outcome and a covariate and, therefore, any method proposed to address
missingness in the mediator needs to consider the mediator in both capacities.
In this Chapter, we examine the impact of ignoring clustering on mediated
effects estimates under MCAR and MAR mechanisms in longitudinal stud-
ies with varying degrees of missingness. We describe a Markov chain Monte
Carlo (MCMC) approach for imputing missing longitudinal data considering
clustering (Schafer, 2001), followed by two imputation approaches that ignore
clustering. We apply the methods to the severe malaria and cognition data
(Cusick et al., 2016), conduct a simulation study, present results from the
three imputation approaches and results when no imputation is conducted,
and conclude the Chapter with a discussion.
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3.2 Methods
3.2.1 Mediation analysis
Consider an outcome Yij, potential mediator Mij, treatment or exposure Ti,
and a vector of potential confounders Ui, i = 1, · · · , n, j = 1, · · · , s for subject
i at time j. Suppose we are interested in whether the effect of the exposure Ti
on the outcome Yis is mediated through Mij. The total effect of the treatment
on the outcome can be decomposed into the average causal mediation effect
(ACME), the effect of treatment on the outcome only through the treatment
effect on the mediator and the average direct effect (ADE), the effect of treat-
ment on the outcome adjusting for the mediator. To compute the ACME and
ADE in a simple mediation analysis, we fit two models (i) E(Yis|Ti = t,Mij =
m,Ui = u) = α0 + α1Ti + α2Mij + U
T
i α
T
u , and (ii) E(Mij|Ti = t, Ui = u) =
β0 + β1Ti + U
T
i β
T
u . Under the assumptions of no unmeasured confounding of
the exposure-mediator relationship, exposure-outcome relationship, mediator-
outcome relationship, and no mediator-outcome confounders associated with
the exposure (Bind et al., 2015; Valeri et al., 2014; van der Laan and Petersen,
2004; VanderWeele, 2010), the ACME is given by α2β1 and the ADE by α1
(Baron and Kenny, 1986) so that the total effect is α1 + α2β1.
3.2.2 Multiple imputation (MI) in mediation analysis
3.2.2.1 Considering clustering using an MCMC approach
In longitudinal data, subjects are repeatedly measured over time and measure-
ments for subject i are clustered within subject, and are correlated. Multiple
imputation methods for correlated data in longitudinal studies have been de-
veloped by Schafer (1997) and Liu et al. (2000). These methods feature a
Markov chain Monte Carlo (MCMC) algorithm that uses a Gibbs sampler
for a multivariate linear mixed effects model for incomplete data (Liu et al.,
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2000; Schafer, 1997; Schafer and Yucel, 2002). To do imputation, we assume
a multivariate extension of the linear mixed effects model
Ri = Xiλ+ Zibi + εi (3.1)
where Ri is an ni × r matrix of responses with missing values, Xi(ni × p) and
Zi(ni× q) are covariate matrices, λ(p×r) is a matrix of regression coefficients,
rows of the residual matrix are independently distributed as εi ∼ N(0,Σ), and
vec(bi) ∼ N(0,Ψ) is a vector of random coefficients, where bi is q × r and vec
denotes the vectorization of a matrix by stacking its columns. Variables with
missing values are included in Ri regardless of whether they are responses or
covariates. When there is missingness in the outcome Yij and mediator Mij,
responses for participant i can be arranged in an s× r matrix with a column
for each variable as (in this case r = 2)
Ri =

yi1 mi1
yi2 mi2
...
...
yis mis
 .
The rows indicate measurements at different time points. In model (3.1), the
covariates are the same for both the outcome and mediator. This poses no
problem since the objective is to impute missing responses while preserving
relations within the data (Schafer, 2001).
Priors for Ψ and Σ are typically chosen to be weak to limit their influence on
results. Schafer (2001) and Schafer and Yucel (2002) recommended indepen-
dent Wishart priors Σ−1 ∼ W (ν1,Λ1) and Ψ−1 ∼ W (ν2,Λ2), where W (ν,Λ)
denotes a Wishart variate with ν > 0 degrees of freedom and mean νΛ > 0.
These priors allow an unstructured Ψ and in practice hyperparameters are cho-
sen such that ν2 = qr where r is the number of variables with missing data, q
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is the dimension of the random effects and Λ−12 = ν2Ψˆ. The value of ν1 is set
to r and Λ−11 = ν1Σˆ. The values for Ψˆ and Σˆ can be obtained from the data
using maximum likelihood estimation (Schafer and Yucel, 2002; Yucel, 2015).
The prior for λ is usually an improper uniform density over Rpr (Schafer, 1997;
Yucel and Demirtas, 2010). The MCMC algorithm is run until convergence.
After convergence, the algorithm draws from the posterior distribution of the
parameters and then imputes missing data values conditional on the drawn
parameter values. These methods are implemented in PAN, an open source
R package that accounts for clustering in MI for longitudinal data (Zhao and
Schafer, 2016). PAN has been described previously (Schafer, 2001; Schafer
and Yucel, 2002).
3.2.2.2 Ignoring clustering using multivariate imputation by chained
equations (MICE)
Multivariate imputation by chained equations (MICE), also refered to as fully
conditional specification (Azur et al., 2011; Van Buuren, 2007) or sequential re-
gression multiple imputation (Azur et al., 2011; Raghunathan et al., 2001) has
been used in a variety of fields to multiply impute missing data (Buuren and
Groothuis-Oudshoorn, 2011). MICE imputes data on a variable-by-variable
basis with the flexibility to specify a different model for each variable. Suppose
Yij and Mij are partially observed and Xij is a set of fully observed covariates.
Data for each subject are stacked together in columns so that subjects have
multiple rows and each row is a subject’s measurement at one time, j. Since
this method ignores clustering, subscripts i and j are subsequently dropped
from Yij, Mij and Xij. Let Y
obs and M obs denote observed values and Y mis and
Mmis denote missing values for Y and M respectively. Initially, missing values
in Y and M are filled in by simple random sampling with replacement from
observed values (White et al., 2011). Using only observed values for Y for all
subjects, Y obs is regressed on M obs and covariates X, producing a set of maxi-
mum likelihood estimates θˆy of θy. A random draw is taken from the posterior
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predictive distribution of θy, to produce a new set of coefficients θ
∗
y. To gener-
ate sufficient variability in the imputed values, θ∗y is drawn from a multivariate
normal distribution with mean θˆy and the estimated covariance of θˆy with an
additional random draw for the residual variance. Using a draw of θ∗y, pre-
dicted values for Y are generated for all cases, Y obs and Y mis. For each Y mis,
a set of five Y obs whose predicted values are nearest to the predicted value for
the case with a missing value are identified. From these nearest neighbors,
one value is randomly chosen and Y mis is replaced by its corresponding ob-
served value. Then M obs is regressed on Y (including the imputed values) and
covariates X, producing another set of coefficients θm. θ
∗
m is drawn from the
posterior predictive distribution of θm as was done for Y and used to generate
predicted values for all M obs and Mmis. For each case with Mmis, five cases
with M obs are identified with predicted values nearest to the predicted value
for the case with a missing value. From the five nearest neighbors, one value is
randomly chosen and its corresponding observed value substituted for Mmis.
This process is repeated g cycles until regression parameters become stable
(Bouhlila and Sellaouti, 2013; White et al., 2011) to produce a single imputed
data set. To stabilize the distribution of regression parameters, 5-10 cycles
have been found to yield satisfactory performance with moderate amounts of
missing data (Brand, 1999; Van Buuren et al., 2006).
3.2.2.3 Linear model (LM) method
This method can be considered when the analysis model is a generalized linear
model rather than a generalized linear mixed model that is consistent with
longitudinal data. It emulates situations when researchers may be interested
in the mediation effect of a change in the mediator from baseline to the end of
the study on the effect of an exposure on the outcome at the end of the study.
This method is similar to ignoring clustering in that it does not use a random
effect. However, only variables at time points needed for analysis are used in
the imputation phase, contrary to using all the data. The LM method uses
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MICE with a non time-varying exposure, outcome, mediator and covariates to
generate imputed data sets.
3.2.3 Pooling results
For each imputation method, several complete data sets are generated with
missing values imputed, say k complete data sets. The k data sets are then
used to fit k models and fixed effect estimates from these models are com-
bined using Rubin’s rules (Rubin, 1987), also described by White et al. (2011).
Briefly, assume that k data sets are imputed and the estimate of interest is βˆ
with estimated variance Vˆ . If βˆl and Vˆl are fixed effect estimates and variance
respectively from the lth (l = 1, 2, . . . , k) imputed data set, then the combined
estimate is βˆ = (1/k)
∑k
l=1 βˆl and the total variance is Var(βˆ) = W + [1 +
(1/k)]B, where W and B are the within-imputation and between-imputation
variances given by W = (1/k)
∑k
l=1 Vˆl and B = [1/(k − 1)]
∑k
l=1(βˆl − βˆ)2
respectively. Some studies have suggested that 3-5 imputed data sets are
adequate (Rubin, 1987; Schafer, 1999; Schafer and Olsen, 1998), though some
have suggested up to 10 data sets (Schafer, 1999) or even more (Graham et al.,
2007).
3.3 Simulation study
We simulated longitudinal data for the mediator M and the outcome Y from
linear mixed models. Yij and Mij were generated for subjects i = 1, 2, . . . , n =
300 at time points j = 1, 2, . . . ,m = 6 such that
Mij = ζ0 + ζ2Ti + ζ3I(j = 2) + · · ·+ ζ7I(j = 6) + ζ8X1 + ζ9X2
+ ζ10TiI(j = 2) + · · ·+ ζ14TiI(j = 6) + bM0i + εMij
Yij = γ0 + γ2Ti + γ3(Mij −Mi1) + γ4I(j = 2) + · · ·+ γ8I(j = 6)
+ γ9X1 + γ10X2 + b
Y
0i + εYij
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where Ti is the treatment for subject i, I is the indicator function, X1 is a
continuous covariate such that X1 ∼ N(10, 1.2), and X2 is a binary covariate
taking each possible value (0 or 1) with probability 0.5. The vectors ζ and γ are
fixed effects for the mediator and outcome data generating models respectively.
We set ζ = (8,−1.7, 3.3, 3.8, 4.3, 4.8, 5.3,−0.3, 1.9,−0.2,−0.6,
−0.5,−0.7,−0.9) and γ = (−1,−1.5, 2.4, 1.2, 1.25, 1.45, 1.6, 1.75, 0.22,−1.55).
The random intercepts and errors were simulated from a multivariate normal
distribution so that the intra-class correlation for both outcome and mediator
is 0.8.εYij
εMij
 ∼ N(
0
0
 ,
1 0
0 1
),
bY0i
bM0i
 ∼ N(
0
0
 ,
4 0
0 4
).
Complete data was first generated and then outcomes at different time points
were set to missing according to a MCAR or MAR mechanism. Observations
at the first time point were always observed and thus non-missing. The miss-
ingness was monotone for MAR, i.e., if the mediator or outcome is missing at
time j < 6, then it is also missing at subsequent time points from j + 1 to
time point 6. Proportions of missingness were 10%, 20%, 30% and 40%. Since
the mediator is both an outcome and a covariate, the MAR mechanism was
mediator dependent in half of the data set and the other half, outcome depen-
dent. The MAR mechanism was determined by the magnitude of the drop in
the outcome or mediator measure from time point to time point, however, val-
ues for the outcome or mediator from which this magnitude can be measured
are retained in the data set. In a longitudinal study with withdrawal, loss to
follow-up, or death, we assume that when the outcome is missing at time j,
we are unable to measure the mediator at the same time j and vice versa.
Thus, when the outcome was missing, the mediator was set to missing too and
vice versa. To generate data consistent with the MCAR mechanism, data was
made missing randomly in the complete data set from time point 2 through 6,
so missingness does not depend on either the observed or unobserved data.
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Multiple imputation for missing values was done, first, ignoring clustering
using multivariate imputation by chained equations (MICE) (Buuren and
Groothuis-Oudshoorn, 2011), second, using the analysis model (3.2) with im-
putation by MICE, referred to as the linear model (LM) method, and third,
considering clustering in the data using PAN R package as described in the
methods section. The linear model (LM) method is a natural approach and is
congenial in the sense of Meng (1994) because the imputation model is similar
to the analysis model. For both ignoring clustering and the LM method, the
number of cycles was fixed at g = 15. The analysis models were
Mi6 −Mi1 = β0 + β1Ti + β2X1 + β3X2 + Mi6
Yi6 = α0 + α1Ti + α2(Mi6 −Mi1) + α3X1 + α4X2 + Yi6 (3.2)
where time point j = 6 is the end of the study. The true ACME was
α2β1 = −2.16 and the true ADE was α1 = −1.50. Missing values for Mij were
imputed first, and then the difference Mi6−Mi1 computed using observed and
imputed values. For each proportion of missingness, 2000 Monte-Carlo data
sets were simulated. For each data set, k = 10 imputations were conducted,
and analyzed using the linear model (3.2) with results pooled using Rubin’s
method (Rubin, 1987). For each imputed data set, the ACME and ADE were
estimated, after which results were pooled. ACME and ADE estimates for all
methods including no imputation were then compared on bias, mean square
error, and the coverage probability of 95% Wald-type confidence intervals.
ACME estimates were also compared on the Sobel standard error (S-SE) (So-
bel, 1982) and ADE estimates on the standard error. The ACME coverage
probability was computed as the percentage of times the true parameter value
was covered by the 95% confidence interval constructed using the S-SE.
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3.4 Results
3.4.1 Simulation results
Simulation results in Table 3.1 indicate that when data are MCAR, for all pro-
portions of missingness, ignoring clustering in the imputation model leads to
biased ACME estimators and that bias increases as the proportion of missing
data increases. Coverage probabilities are below the nominal 95% and decrease
as the proportion of missing data increases. Since the Monte-Carlo standard
deviation (MC-SD) was closer to the mean Sobel standard error (MS-SE),
an estimator for the ACME standard error, though lower than for complete
data, lower coverage probabilities are a consequence of bias in the ACME es-
timator, which shifts confidence intervals away from the true ACME. On the
other hand, no imputation, imputing using the LM, and considering cluster-
ing gave unbiased estimators and a coverage probability close to 95% for all
proportions of MCAR. Considering clustering had the lowest MSEs compared
to no imputation, ignoring clustering and the LM method. We also compared
the methods according to the MS-SE. For all proportions of missing data, the
MS-SEs when clustering was ignored were lower than when LM was used or
when clustering was considered in the imputation model. When 10% of data
was MCAR, the MSEs for LM and considering clustering were close to that of
complete data. However, for 20%-40% proportions of missingness, considering
clustering consistently gave lower MSEs compared to the LM method and this
difference in MSEs increased as the proportions of missing data increased.
When data were MAR, ACME estimators were unbiased at up to 30% pro-
portions of missing data when clustering was considered in the imputation
model (Table 3.1). ACME estimators for all considered proportions of missing
data for no imputation and ignoring clustering in the imputation model were
biased and bias in the estimator increased as the proportion of missing data
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increased. In fact, ignoring clustering had the most biased ACME estimators
and as the proportion of missing data increased, the ACME estimator became
more biased towards the null. Moreover, the bias was greater when data was
MAR than when it was MCAR. The ACME estimator for imputation using
the LM method was biased for MAR data, but the bias was lower compared to
no imputation and ignoring clustering. The MSE was highest when clustering
was ignored compared with the other methods for all proportions of missing
data, and increased as the proportion of missing data increased. Considering
clustering had the lowest MSE for all proportions of missing data. MS-SEs ig-
noring clustering were five times higher than those for other methods including
when no imputation was done. Coverage rates for no imputation, considering
clustering and the LM method were close to the nominal 95% at all proportions
of missing data but not when clustering was ignored.
Table 3.1 Simulation results: average causal mediation effect (ACME) esti-
mates when no imputation is conducted and after multiple imputation using
different approaches in longitudinal data for differing proportions of missing
data.
Prop. Method Missing completely at random (MCAR) Missing at random (MAR)
Estimate Bias MSE MC-SD MS-SE CP Estimate Bias MSE MC-SD MS-SE CP
Complete -2.16 0.00 0.17 0.41 0.40 0.95 -2.16 0.00 0.17 0.41 0.40 0.95
10% No imputation -2.18 -0.02 0.18 0.42 0.42 0.96 -2.26 -0.10 0.19 0.43 0.42 0.94
IC -1.49 0.67 0.57 0.35 0.38 0.58 -1.24 0.92 0.98 0.37 0.34 0.26
LM -2.16 0.00 0.18 0.42 0.42 0.96 -2.24 -0.08 0.19 0.43 0.42 0.94
CC -2.16 0.00 0.17 0.41 0.41 0.96 -2.13 0.03 0.17 0.42 0.41 0.95
20% No imputation -2.15 0.01 0.20 0.45 0.45 0.95 -2.28 -0.12 0.22 0.45 0.45 0.94
IC -1.07 1.09 1.26 0.28 0.34 0.11 -0.81 1.35 1.92 0.30 0.30 0.02
LM -2.11 0.05 0.20 0.45 0.45 0.95 -2.25 -0.09 0.21 0.45 0.45 0.94
CC -2.12 0.04 0.18 0.42 0.42 0.95 -2.07 0.09 0.19 0.43 0.43 0.94
30% No imputation -2.18 -0.02 0.23 0.48 0.48 0.95 -2.35 -0.19 0.28 0.49 0.49 0.94
IC -0.83 1.33 1.82 0.25 0.31 0.01 -0.58 1.58 2.56 0.26 0.27 0.00
LM -2.13 0.03 0.23 0.48 0.47 0.94 -2.29 -0.13 0.27 0.50 0.48 0.93
CC -2.13 0.03 0.20 0.44 0.44 0.94 -2.08 0.08 0.21 0.45 0.44 0.94
40% No imputation -2.16 0.00 0.28 0.53 0.52 0.94 -2.36 -0.20 0.33 0.54 0.54 0.94
IC -0.64 1.52 2.35 0.22 0.28 0.00 -0.42 1.74 3.09 0.23 0.25 0.00
LM -2.07 0.09 0.29 0.53 0.51 0.92 -2.26 -0.10 0.31 0.54 0.52 0.93
CC -2.08 0.08 0.23 0.48 0.46 0.93 -2.04 0.12 0.25 0.49 0.47 0.93
CC, Considering clustering; CP, Coverage probability; IC, Ignoring cluster-
ing; LM, Linear model; MC-SD, Monte-Carlo standard deviation; MSE, Mean
square error; MS-SE, Mean Sobel standard error; Prop, Proportion of missing
data. True ACME = -2.16, sample size = 300, and number of Monte-Carlo
data sets = 2000.
When data is MCAR, average direct effect (ADE) estimators with no impu-
tation, considering clustering in the imputation models and the LM method
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were approximately unbiased but not for ignoring clustering (Table 3.2). Con-
sidering clustering gave the lowest MSE at all proportions of missing data, in
fact, similar to when data is complete. On the other hand, when clustering
was ignored, MSEs were higher than other methods, over eight times the MSE
for complete data. Coverage probabilities were close to 95% at all proportions
of missing data for all methods except for ignoring clustering.
When data were MAR, considering clustering performed better than all other
methods in terms of bias, MSE and coverage rates (Table 3.2). ADE estima-
tors for no imputation, ignoring clustering, and the LM method were biased
at all proportions of missing data. In fact, ignoring clustering in the imputa-
tion model had the most biased ADE estimators and the bias increased as the
proportion of missing data increased. MSEs for considering clustering were
similar to when data was complete, and increased slightly as the proportion
of missing data increased. Coverage probabilities for all methods except con-
sidering clustering were below the nominal 95% at all proportions of missing
data. As the proportion of data MAR increased, coverage probabilities for
ignoring clustering decreased.
In this simulation, we first imputed missing data for both the outcome and the
mediator and then computed Mi6−Mi1 using both observed and imputed data.
We also conducted a simulation where Mij−Mi1 were first calculated and then
missing values for the outcome Yij and Mij−Mi1 imputed, after which ACME
and ADE were estimated. Results were similar for ACME although the bias
was lower for ignoring clustering than under the former approach. ADE esti-
mators for all methods (no imputation, ignoring clustering, LM method, and
considering clustering) were approximately unbiased when data was MCAR.
However, except considering clustering, ADE estimators for all other methods
were biased when data was MAR (appendix B).
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Table 3.2 Simulation results: average direct effect (ADE) estimates when
no imputation is conducted and after multiple imputation using different ap-
proaches in longitudinal data for differing proportions of missing data.
Prop. Method Missing completely at random (MCAR) Missing at random (MAR)
Estimate Bias MSE MC-SD Avg-SE CP Estimate Bias MSE MC-SD Avg-SE CP
Complete -1.49 0.01 0.07 0.27 0.27 0.95 -1.49 0.01 0.07 0.27 0.27 0.95
10% No imputation -1.51 -0.01 0.08 0.28 0.29 0.95 -1.37 0.13 0.10 0.28 0.28 0.92
IC -2.20 -0.70 0.62 0.37 0.43 0.66 -2.54 -1.04 1.23 0.38 0.43 0.30
LM -1.51 -0.01 0.08 0.28 0.29 0.95 -1.37 0.13 0.10 0.28 0.28 0.92
CC -1.52 -0.02 0.08 0.27 0.28 0.95 -1.54 -0.04 0.08 0.27 0.28 0.95
20% No imputation -1.51 -0.01 0.09 0.31 0.31 0.94 -1.29 0.21 0.13 0.30 0.29 0.89
IC -2.59 -1.09 1.41 0.46 0.49 0.39 -2.86 -1.36 2.04 0.44 0.48 0.18
LM -1.51 -0.01 0.10 0.31 0.31 0.94 -1.29 0.21 0.13 0.30 0.30 0.88
CC -1.54 -0.04 0.08 0.29 0.28 0.94 -1.56 -0.06 0.09 0.29 0.29 0.94
30% No imputation -1.48 0.02 0.10 0.32 0.33 0.95 -1.21 0.29 0.18 0.31 0.32 0.85
IC -2.86 -1.36 2.08 0.49 0.54 0.27 -3.03 -1.53 2.59 0.48 0.53 0.16
LM -1.48 0.02 0.11 0.33 0.33 0.95 -1.21 0.29 0.18 0.32 0.32 0.85
CC -1.54 -0.04 0.08 0.28 0.29 0.95 -1.57 -0.07 0.09 0.29 0.30 0.95
40% No imputation -1.49 0.01 0.13 0.36 0.35 0.95 -1.17 0.33 0.23 0.35 0.35 0.84
IC -3.05 -1.55 2.72 0.56 0.59 0.24 -3.13 -1.63 2.99 0.56 0.59 0.20
LM -1.49 0.01 0.13 0.36 0.36 0.94 -1.17 0.33 0.23 0.35 0.35 0.83
CC -1.57 -0.07 0.09 0.29 0.30 0.96 -1.59 -0.09 0.10 0.30 0.31 0.94
CC, Considering clustering; CP, Coverage probability; IC, Ignoring cluster-
ing; LM, Linear model; MC-SD, Monte-Carlo standard deviation; MSE, Mean
square error; Avg-SE, Average standard error; Prop, Proportion of missing
data. True ADE = -1.50, sample size = 300 and number of Monte-Carlo data
sets = 2000.
3.4.2 Data application example: Severe malaria and
cognition data
In this longitudinal study, 70 children with cerebral malaria (CM) and 83
community control (CC) children 18 months to 5 years of age were enrolled
to study the effects of iron deficiency and severe malaria on neurocognitive
development. All children with CM were iron deficient while only 35 out of
83 CC children were iron deficient at baseline. Children with severe malarial
anemia (SMA) were also enrolled in the study, but excluded from this analysis
because their inclusion was restricted on the mediator (hemoglobin levels ≤ 5
mg/dl). Community control children were recruited from the nuclear family,
neighbourhood, or extended family of children with CM or SMA and were
within 1 year in age of a recently enrolled CM or SMA child but not matched
to CM or SMA children. Cognitive ability was measured using the Mullen
Scales of Early Learning (Mullen et al., 1995). Sub-scale scores for visual re-
ception, fine motor, expressive language, and receptive language were summed
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to give the Mullen composite score, a measure of overall cognitive ability. Mea-
surements of the outcome (cognitive ability) and mediator (hemoglobin) were
made at baseline (0 months), 6 months and 12 months. Variables predictive
of missingness for hemoglobin and cognitive ability included socioeconomic
status, baseline weight-for-height, mother’s education level, and whether the
child had any education yet. One CC child who was missing values for two
predictive variables for missingness (socioeconomic status and any child edu-
cation) was excluded from the analysis.
CM has been associated with long-term neurocognitive impairment (Bangi-
rana et al., 2014; Boivin et al., 2007; John et al., 2008) and hemoglobin level
has been suggested to mediate the effect of malaria on neurocognition (Boivin
et al., 2016). In this study, data can be missing for both the outcome and me-
diator at all time points. Percentages of missing data by variable are displayed
in Table 3.3.
Table 3.3 Percent (%) missing at each time point for model variables
(N = 152).
Variable Baseline (0 months) 6 months 12 months
Cognitive ability† 1 11 20
Hemoglobin 1 12 7
Age 1 2 3
† Cognitive ability, the outcome, is a composite score that is a sum of 4
scales, visual reception, fine motor, expressive language and receptive
language.
We sought to examine the mediation effect of sustained levels of hemoglobin
early in follow-up (measured by the average of hemoglobin levels at baseline
and 6 months) on the effect of CM on changes in neurocognition from baseline
to 12 months. First, we analyzed the data using linear regression in R without
any imputation for missing data. Second, we imputed imputed missing data
values ignoring clustering using MICE (Buuren and Groothuis-Oudshoorn,
2011). Third, we imputed missing values assuming a linear imputation model
for average hemoglobin and change in neurocognition and lastly, we imputed
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missing values considering the clustering in the data. Following imputation,
missing values for average hemoglobin and change in neurocognition were cal-
culated using observed and imputed values. Ten data sets were imputed for
each imputation method and pooled results are displayed in Table 3.4. For
all four methods except for ignoring clustering (which found borderline sig-
nificance, p=0.093), the estimated ACMEs were significant. For example, for
considering clustering, the ACME = 5.14 (S-SE = 2.56, p = 0.045) captures
the effect on changes in neurocognition as a result of CM, but only through
CM’s effect on average hemoglobin. ACME estimates varied across methods.
No imputation assumes data is MCAR, which may not be the case. The LM
method does not use all the data during imputation and ignoring clustering
assumes all observations within subject are independent, yet they are corre-
lated. With non-significant direct effects for all methods, these results suggest
that the effect of CM on changes in neurocognition is possibly mediated by
initial levels of hemoglobin. The standard error for ACME when clustering
is ignored is slightly inflated compared to other methods in the imputation
model. These results suggest possible mis-estimation of standard errors when
clustering is ignored in the imputation model.
Table 3.4 Malaria-cognition data: average causal mediation effect (ACME)
and average direct effect (ADE) estimates after multiple imputation using a
linear model, considering and ignoring clustering.
Imputation method ACME ADE
Estimate (S-SE) p value Estimate (SE) p value
No imputation 8.40 (2.94) 0.004 -5.63 (3.76) 0.137
Ignoring Clustering 5.35 (3.19) 0.093 -2.95 (4.27) 0.490
LM imputation 7.05 (2.68) 0.009 -4.76 (3.49) 0.173
Considering clustering 5.14 (2.56) 0.045 -3.54 (3.35) 0.291
LM, Linear model; SE, Standard error; S-SE, Sobel standard error.
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3.5 Discussion
The main objective of this Chapter was to evaluate the effects on mediation
effect estimates of misspecifying the imputation model by ignoring clustering
when data is clustered due to repeated measures on the same subject. We
found that under the scenarios considered, ACME and ADE estimators for
ignoring clustering when data is MCAR or MAR are biased at all moderate
rates of missing data. Considering clustering in the imputation model per-
formed better than ignoring clustering at all rates of missing data in terms of
bias, MSE, and coverage probability. The magnitude of bias in the ACME and
ADE estimators when clustering was ignored increased with increasing rates
of missing data, while considering clustering provided approximately unbiased
ACME and ADE estimators at rates of missing data of up to 40%. ACME and
ADE estimators for no imputation and the LM method were approximately
unbiased when data was MCAR. To impute missing data ignoring clustering,
we used the MICE R package (Buuren and Groothuis-Oudshoorn, 2011) which
assumes independent observations, suitable for normal models such as linear
regression. This is inconsistent with correlated observations, which are com-
mon in longitudinal studies.
Our results are consistent with previous findings for cluster randomized trials,
where considering clustering gave approximately unbiased fixed effect esti-
mates compared to ignoring clustering (Black et al., 2011), although at 10%
rate of MAR, fixed effects from multiply imputed data ignoring clustering were
generally unbiased and comparable in accuracy to those considering clustering.
In the same study, as rates of missing data increased under a MAR mecha-
nism, accuracy of fixed effects decreased and the within-subject variance was
overestimated when clustering was ignored (Black et al., 2011). The overes-
timation of within-subject variance was attributed to underestimation of the
between-subject variance (Black et al., 2011; Taljaard et al., 2008). Although
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the imputation methods varied, two-level clustered data was generated and
analyzed using a linear mixed model.
Our simulation is not congenial in the sense of Meng (1994) since the analysis
model cannot be derived from the imputation model. However, the statistical
community agrees that for better inference, data relationships and character-
istics within and between clusters need to be preserved during the imputation
phase. A difference in the current study is that data was simulated using a lin-
ear mixed model but analyzed using a linear model. In addition, data that was
MAR was set to depend on both the outcome and the mediator. Compared
to results for complete data, ACME standard error estimates when clustering
was ignored were consistently lower for all missing data proportions. Black
et al. (2011)’s results in cluster randomized trials, indicating potential bias in
variance estimates when the multiple imputation model is misspecified, are
consistent with the current results where ACME standard errors are underes-
timated. In estimating the mediation effect of Mi6−Mi1, these results suggest
that ignoring clustering in the imputation model can cause underestimation
of ACME standard errors. To compute the ACME, we compute the product
of two fixed effects. When clustering is ignored in the imputation model, the
bias inherent in each of the fixed effect estimates is amplified in their prod-
uct. When fixed effects are of interest and there is a high rate of missingness,
or when inferences on variance components are of interest, studies conducted
in cluster randomized trials discourage ignoring clustering in the imputation
model (Black et al., 2011).
Another method that has been used to account for clustering in the impu-
tation model is including indicators of cluster membership as fixed effects.
This drastically increases the number of fixed effects to estimate in longitudi-
nal studies because such studies can have hundreds of individuals considered as
clusters. Moreover, including dummy variables indicating cluster membership
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in the context of CRTs has been found to lead to severe over-estimation of
variance of group means, and that the over-estimation is severe for small clus-
ter sizes and small intra-class correlation (Andridge, 2011). A hybrid strategy
where half of the time one imputes from a model with cluster dummy variables
as fixed effects and the other half multiply imputing from normal model impu-
tation has also been tested. Using the MCMC approach to allow for clustering
still performed better than this hybrid strategy (Zhou et al., 2014).
In this study, we imputed a continuous outcome and mediator. A limitation in
using PAN to account for clustering in the imputation model for longitudinal
data is that it uses a multivariate linear mixed effects model. When categori-
cal data is missing and treated as multivariate normal in the PAN model, it is
unclear what kind of biases this can introduce. Horton et al. (2003) point out
that rounding off multivariate normal imputed values for dummy variables to
make them plausible can cause more bias than using the originally imputed
implausible value. On the other hand, one could use probability mean match-
ing (pmm), available in MICE, though the bias associated with ‘pmm’ for
categorical variables in clustered data needs more investigation.
We have demonstrated that ignoring clustering in the imputation model when
data is MCAR or MAR provides biased ACME and ADE estimates in longitu-
dinal studies. To get unbiased ACME and ADE estimates and good coverage
probabilities at moderate rates of missing data, considering clustering under
the linear mixed effects model in the imputation model is recommended.
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Chapter 4
Mediation effects of malaria
prevention in pregnant women
on child neurodevelopment: a
randomized controlled trial
4.1 Introduction
Children under five years are particularly vulnerable to malaria illness, infec-
tion and death. In 2015, out of the estimated 303,000 malaria deaths globally
in children under 5 years, 96% were from the African region (WHO, 2015). The
effects of malaria on childhood development may start in utero. Particularly,
pregnant women are more at risk of Plasmodium falciparum malaria infection
than non-pregnant women (Brabin, 1983; Rogerson et al., 2007). Malaria in-
fection in pregnancy leads to placental malaria (PM) (Rogerson et al., 2007)
and PM, seen in 26-28% (Guyatt and Snow, 2004; Steketee et al., 2001) of all
pregnant women, has been associated with low levels of hemoglobin, low birth
weight and pre-term birth (Conroy et al., 2013; Desai et al., 2007; Kapisi et al.,
2017; Katz et al., 2013; Rogerson et al., 2007, 2003). In malaria endemic areas,
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malaria in pregnancy accounts for 8-36% of low birth weight babies (Steketee
et al., 2001). Moreover, malaria is an important cause of maternal anemia
(Desai et al., 2007), and anemia is an independent risk factor for low birth
weight and fetal growth restriction (Hendrix and Berghella, 2008). Animal
models suggest that maternal infection can lead to impairment in neurologic
function in the offspring, even in the absence of fetal infection (Ozawa et al.,
2006; Shi et al., 2005; Urakubo et al., 2001). Maternal systemic and placental
changes such as placental inflammation (Muehlenbachs et al., 2006) and PM
that occur with malaria illness in pregnancy can adversely affect the developing
fetal brain, and fetal brain injury affects long term childhood neurodevelop-
ment (ND). The inflammatory response against malaria triggered in pregnant
mothers reduces the amount of key nutrients in maternal circulation and thus
available for transfer to the fetus, leading to functional deficiencies of several
key micronutrients, notably iron and zinc, that are essential to brain devel-
opment in the first 1000 days of life (Nelson et al., 2001; Okoko et al., 2003).
Thus, preventing malaria during pregnancy is fundamental.
In areas in Africa with moderate to high malaria transmission, the World
Health Organization (WHO) recommends intermittent preventive treatment
in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP), as part of antena-
tal care services (WHO, 2016). However, some studies in infants and pregnant
women found an increased risk of anemia among those who received intermit-
tent preventive treatment (IPT) with SP (Bigira et al., 2014; Gosling et al.,
2009; Harrington et al., 2011). In addition, one study that compared the ef-
fectiveness between IPTp with SP and insecticide treated nets (ITNs) found
no differences in low birth weight (LBW), maternal anemia, placental para-
sitemia, and peripheral parasitemia (Ndyomugyenyi et al., 2011). WHO also
recommends that all pregnant women receive iron and folic acid supplemen-
tation as a part of routine antenatal care (WHO, 2016). However, folic acid
can interfere with the efficacy of SP prophylaxis because SP inhibits dihydro-
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folate reductase and, therefore, dihydroartenisinin-piperaquine (DP) prophy-
laxis, presumably unaffected by folic acid, could be an alternative option. IPT
with DP in children has shown promising results in protecting them against
clinical malaria, parasitemia, and anemia (Nankabirwa et al., 2014), though
the effects of its use in pregnancy on the children’s ND is not well understood.
In a high malaria transmission setting, IPTp with DP has shown superior-
ity in lowering the burden of malaria among pregnant women compared to
IPTp with SP, with higher doses of DP providing more protection (Kakuru
et al., 2016). Malaria infection that spreads to the placenta (Rogerson et al.,
2007), coupled with maternal anemia, can cause preterm birth and intrauterine
growth retardation (IUGR) (Conroy et al., 2013; Lagerberg, 2008); individu-
ally or in combinations these effects can affect a child’s ND. Asymptomatic or
severe forms of malaria in children have been associated with deficits in neu-
rodevelopment (Al Serouri et al., 2000; Boivin et al., 2007; John et al., 2008;
Nankabirwa et al., 2013) while children with lower hemoglobin have been asso-
ciated with poorer test scores (Al Serouri et al., 2000; Fernando et al., 2003).
Although one study found that anemia mediates the effect of repeated episodes
of malaria illness on cognitive development in young children (Boivin et al.,
2016), the role of cord blood hemoglobin in mediating the effect of mater-
nal asymptomatic or symptomatic malaria during pregnancy on their child’s
ND is unclear. In this study, we expect that the protective effect of IPTp
causes placental changes that reduce effects of malaria in pregnancy such as
placental malaria, preterm birth, low birth weight, and low levels of cord blood
hemoglobin levels, thus improving ND in the offspring.
Formally, we hypothesize that maternal malaria infection or placental malaria,
adverse birth outcomes measured by preterm birth, LBW or small for gesta-
tion age (SGA), cord blood hemoglobin levels, and child malaria (referred to
as mediators) mediate the effect of IPTp on children’s ND. The purpose of
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this study, therefore, was to estimate indirect (mediation) effects of IPTp in
pregnant women on child ND.
4.2 Methods
4.2.1 Study description
The data are from a prospective longitudinal cohort study (PROTECT) con-
ducted in Tororo District, Uganda. Tororo is in Eastern Uganda where malaria
is highly endemic throughout the year with an estimated entomological inocu-
lation rate of 310 infectious bites per person year in 2012 (Kamya et al., 2015).
This study was nested within a randomized, double-blinded, controlled trial
(PROMOTE-II) (Kakuru et al., 2016) of which the objective was to evalu-
ate promising interventions to reduce the burden of malaria among pregnant
women and improve maternal child health. In the parent study (PROMOTE-
II), pregnant women presenting for routine care at the Tororo District hospital
antenatal clinic were approached for enrollment between June and October
2014. HIV uninfected women between 12-20 weeks of gestation, 16 years of
age or older, living within 30 kilometers of the study clinic, and intending to
deliver at the hospital were enrolled into the PROMOTE-II study. They were
randomized to receive either three-dose SP, three-dose DP or monthly DP for
IPTp. All doses of SP administered were directly observed in the clinic and
the first of three doses of DP were directly observed in the clinic. The second
and third doses of DP were administered at home. Children born to mothers
randomized to receive three-dose SP during pregnancy received DP every three
months between 2-24 months of age. Children born to mothers randomized
to receive three-dose DP or monthly DP during pregnancy received either DP
every three months or monthly DP between 2-24 months of age. Pregnant
women who had a history of serious adverse events to SP or DP, had a chronic
condition requiring frequent medication, had prior SP prevention therapy or
48
any other antimalarial therapy during pregnancy, or intended to move more
than 30 kilometers from the study clinic were excluded from PROMOTE-II
study. In the current study, children (study participants) born to mothers in
the PROMOTE-II study were enrolled if they were HIV uninfected, 12 months
of age, and within 30 km of the clinic. The exclusion criteria for the children
included serious adverse events to study drugs, active illness at enrollment, his-
tory of head trauma or coma, cerebral palsy or other neurologic disease, known
chronic illness requiring medical care, major medical abnormalities, and known
development delay. All mothers received a long lasting insecticide-treated bed
net (LLIN) at birth.
4.2.2 Neurodevelopment outcome and mediator mea-
surements
Children’s ND was assessed at 12 and 24 months using the Bayley scales of
Infant and Toddler Development (third edition) (Bayley, 2006). The Bayley
scales are easy to use to test children from ages 1 month to 42 months and are
widely used to assess neuropsychological domains in children. They include
tests of cognitive ability, expressive language, receptive language, fine motor
and gross motor. Potential mediators of maternal IPTp included placental
malaria, adverse birth outcomes, cord blood hemoglobin, maternal malaria
measured monthly throughout pregnancy, and child malaria measured monthly
throughout followup. Measures of placental malaria at delivery included de-
tection of malaria parasites in placental blood by both microscopy and loop-
mediated isothermal amplification (LAMP), and histopathologic evidence of
placental malaria (parasites and/or pigment) from placental biopsies (Kakuru
et al., 2016; Kapisi et al., 2017). A child had an adverse birth outcome if
they either had a pre-term birth (< 37 weeks gestation age), were small for
gestation age (<10th percentile) or had a low birth weight (<2.5 kilograms
according to East African fetal weight standards) (Schmiegelow et al., 2012).
49
4.2.3 Laboratory procedures
At enrollment, mothers were evaluated for Plasmodium parasitemia and there-
after were evaluated monthly throughout their pregnancy. At birth, biological
specimens were collected, including placental tissue and placental blood, to
determine their placental malaria status. Pregnant women were encouraged
to deliver in the hospital that was adjacent to the study clinic and when they
delivered at home, they were visited by the study staff at delivery or soon
afterwards. Blood smears were stained with 2% Giemsa and read by trained
laboratory technologists not involved in patient care. A blood smear was con-
sidered negative when the examination of 100 high-power fields did not reveal
asexual parasites. All slides were read by a second reader and a third reader
settled any discrepancy between readings. Placental tissues were processed for
histologic evidence of placental malaria as described previously (Natureeba
et al., 2014). Histological slides were read in duplicate by two trained inde-
pendent readers, and the results were recorded on a standardized case-record
form; any discrepant results were resolved by a third reader. Placental malaria
was defined as presence of infected erythrocytes in the intervillious space (IVS)
by histological examination of placental biopsies. For mothers who gave birth
to twins, delivery outcomes were based on whether the outcome was present in
either child or in the placenta. Children who had a temperature > 38.0◦C or
reported a history of fever in the past 24 hours were tested for malaria. Blood
was obtained by finger prick for a thick blood smear in very young children,
but heel pricks were used too to substitute for finger pricks.
4.2.4 Ethical approval
Informed consent was obtained from the caregivers of all children at enroll-
ment. The Makerere University School of Medicine Research and Ethics Com-
mittee, the Indiana University Institutional Review Board, and the Uganda
National Council of Science and Technology reviewed and approved the PRO-
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TECT study. PROMOTE-II, the parent study study was also approved by
the University of California, San Francisco, Committee on Human Research.
4.3 Randomization
4.3.1 Allocation and blinding
Pregnant women were randomized in a ratio of 2:1:1:1:1 to one of the five
treatment arms A-E in Table 4.1 respectively. A randomization list was com-
Table 4.1 Malaria intermittent preventive treatment (IPT) assignment dur-
ing pregnancy and infancy.
Phase of IPT Intermittent preventive treatment arm
A B C D E
During pregnacy 3 dose SP 3 dose DP 3 dose DP Monthly DP Monthly DP
During infancy 3 monthly DP 3 monthly DP Monthly DP 3 monthly DP Monthly DP
SP, Sulfadoxine-Pyrimethamine; DP, Dihydroartemisinin-Piperaquine.
puter generated by a project member not directly involved in the conduct of
the study using permuted blocks of size 6 and 12. Prior to the PROMOTE-II
study, a set of sequentially numbered, opaque, sealed envelopes were prepared.
Each envelope was marked with a treatment allocation number and the en-
velope contained a piece of paper with both the treatment allocation number
and the IPTp group assignment. IPTp allocation to pregnant women was done
by the responsible study pharmacist. All study drugs were prepackaged by a
study pharmacist and administered by a study nurse blinded to the pregnant
women’s IPTp group. Study personnel who conducted ND testing for the
children were blinded to both the mother’s IPTp and child’s chemopreventive
malaria prophylaxis.
4.3.2 Statistical methods
Characteristics for the pregnant women and children born to them were sum-
marized using frequencies (percent) for categorical data and means (standard
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deviations) for continuous data. Data were analyzed using the intention-to-
treat approach. IPTp effects on each mediator were estimated by regressing
each mediator on IPTp using linear regression for cord blood hemoglobin and
logistic regression for binary mediators. Mediator effects on ND outcomes were
estimated by regressing each ND outcome on each mediator by fitting linear
regression models.
To estimate the mediation effects, the effect of IPTp on ND through each
mediator, we fitted two models; 1) regressed each mediator on IPTp, adjust-
ing for the child’s malaria chemopreventive prophylaxis and 2) separately for
each ND outcome measure at 12 and 24 months, we regressed each outcome
on IPTp, adjusting for the child’s chemopreventive prophylaxis, a mediator,
and we included a mediator-IPTp interaction term. Logistic regression mod-
els were fitted for the mediators maternal malaria, placental malaria, adverse
birth outcome, and child malaria, while linear regression models were fitted for
the mediator cord blood hemoglobin and for ND outcome measures. Media-
tion effects were then computed using the product method (Baron and Kenny,
1986; Valeri et al., 2014) (supplementary materials C.5). Mediation effects of
three-dose DP or monthly DP during pregnancy on child ND outcome mea-
sures through the mediators were computed among maternal three-doses DP
and monthly DP study groups. We present 95% percentile bootstrap confi-
dence intervals for the indirect effects. Some pregnant women with placental
malaria were not diagnosed with malaria during pregnancy and vice versa. A
binary mediator “any maternal malaria” (either placental or maternal malaria
or both) versus neither, was created and mediation effects estimated.
Due to potential interaction between IPTp and child malaria prophylaxis in
preventing child malaria, an exposure variable (mother-child prophylaxis) that
included different mother-child prophylaxis combinations was created. Medi-
ation effects of any maternal malaria (M1) and child malaria (M2) were esti-
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mated concurrently by 1) regressing any maternal malaria or child malaria on
mother-child prophylaxis and 2) separately for each ND outcome measure at
24 months, we regressed each outcome on mother-child prophylaxis, adjusting
for any maternal malaria and for child malaria. We estimated the total indirect
effect and mediation effects through only M1, through only M2, through both
M1 and M2 (supplementary materials C.6) with their 95% percentile boot-
strap confidence intervals. Malaria episodes by the 12-month followup were
very few and, therefore, 12-month outcomes were excluded from this analy-
sis. The analysis was for hypothesis generation and, therefore, no adjustment
was done for multiple testing. All statistical analyses were conducted using R
version 3.2.2 (R Core Team, 2015).
4.4 Results
4.4.1 Trial profile, baseline, during pregnancy and at
birth characteristics
We screened 386 pregnant women, 300 were randomized to one of three malaria
prophylaxes, and 289 were followed up to delivery. There were 291 live births
out of 297 births and 272 children of randomized pregnant women were en-
rolled and tested at 12 months. Among the live births, 6 died, 3 withdrew
consent, 3 moved out of the study area, 4 were unable to be located > 60
days, 2 were unable to comply with the study protocol, and 1 declined to
participate in the study. Mothers of 94, 87, and 91 children had been random-
ized to receive three-dose SP, three-dose DP, and monthly DP respectively
(Figure 4.1). Baseline and clinical characteristics at enrollment were similar
across IPTp groups (Table 4.2). Among the 272 children who were enrolled
at 12 months, 251 (92.3%) were followed and tested at 24 months (Figure 4.1).
Thirty three percent (31/94) of pregnant women who received three-dose SP
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had at least one malaria episode during pregnancy compared to 16.1% and
11.0% among those who received three-dose DP and monthly DP respectively.
Placental malaria at birth was highest among pregnant women who received
three-dose SP (51.6%) compared to 36.0% and 27.8% among those who re-
ceived three-dose DP and monthly DP groups respectively. There was no
significant difference in adverse birth outcomes (low birth weight, small for
gestation age or preterm birth) between IPTp groups (P = 0.744). Any ma-
ternal malaria (i.e. either maternal or placental malaria) was significantly
higher among pregnant women who received three-dose SP compared to other
IPTp groups (P = 0.002) (Table 4.2). Neurodevelopment outcomes at both
12 and 24 months did not differ across IPTp groups (Table 4.3).
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Figure 4.1 Enrollment, randomization and follow-up for study participants
and their mothers.
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Table 4.2 Baseline and clinical characteristics of study participants and their
mothers.
Characteristics Three-dose SP Three-dose DP Monthly DP P
N=94 N=87 N=91
At enrollment
Child’s sex, female (%) 48 (51.1) 42 (48.3) 46 (50.5) 0.925
Highest education level, no. (%) 0.348
None 6 (6.4) 3 (3.4) 1 (1.1)
Primary 70 (74.5) 66 (75.9) 64 (70.3)
O level 16 (17.0) 17 (19.5) 25 (27.5)
A level and higher 2 (2.1) 1 (1.1) 1 (1.1)
Gestational age in weeks, mean (sd) 15.16 (2.05) 15.36 (1.90) 15.30 (1.94) 0.776
Gravidity, no.(%) 0.973
1 34 (36.2) 30 (34.5) 32 (35.2)
2 30 (31.9) 25 (28.7) 28 (30.8)
≥3 30 (31.9) 32 (36.8) 31 (34.1)
Household wealth index, no. (%) 0.471
Lowest tertile 34 (36.2) 28 (32.2) 32 (35.2)
Middle tertile 28 (29.8) 35 (40.2) 26 (28.6)
Highest tertile 32 (34.0) 24 (27.6) 33 (36.3)
Prior malaria episodes, mean (sd) 0.09 (0.28) 0.03 (0.18) 0.11 (0.31) 0.160
Hemoglobin in g/dl at enrollment, mean (sd) 11.87 (1.47) 11.84 (1.11) 12.01 (1.41) 0.660
During pregnancy or at birth
Total episodes of malaria, mean (sd) 0.46 (0.74) 0.17 (0.41) 0.11 (0.31) <0.001
Malaria episodes diagnosed, any (%) 31 (33.0) 14 (16.1) 10 (11.0) <0.001
Maternal blood microscopy, no.(%) 0.139
Negative 90 (95.7) 86 (98.9) 90 (98.9)
Positive 4 (4.3) 1 (1.1) 0 (0.0)
Results missing 0 (0.0) 0 (0.0) 1 (1.1)
Any placental malaria, Yes (%) 47 (51.6) 31 (36.0) 25 (27.8) 0.004
Positive samples by LAMP, any (%) 88 (93.6) 69 (79.3) 66 (72.5) 0.001
Cord blood hemoglobin in g/dl, mean (sd) 14.29 (1.93) 13.65 (2.71) 14.51 (2.00) 0.040
Maternal anemia at birth (Hb<11 g/dl), Yes (%) 16 (17.4) 16 (18.4) 15 (16.5) 0.945
Birth weight in kg, mean (sd) 2.95 (0.45) 2.90 (0.53) 2.94 (0.38) 0.754
Preterm birth, Yes (%) 8 (8.5) 13 (14.9) 4 (4.4) 0.050
Small for gestation age (<10th percentile), Yes (%) 24 (25.5) 14 (16.1) 26 (28.6) 0.124
Adverse birth outcome, Yes (%)† 32 (34.0) 25 (28.7) 29 (31.9) 0.744
Any maternal malaria, Yes (%)‡ 57 (61.3) 38 (44.2) 32 (35.6) 0.002
g/dl, grams per deciliter; Hb, Hemoglobin; kg, Kilograms; LAMP, Loop-
mediated isothermal amplification; sd, Standard deviation; SP, Sulfadoxine-
Pyrimethamine; DP, Dihydroartemisinin-Piperaquine.
†Composite for children who either had a low birth weight (< 2.5kg), were
small for their gestation age (<10th percentile) or whose birth was preterm.
‡Includes mothers who either had maternal or placental malaria versus neither
of the two.
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Table 4.3 Neurodevelopment outcomes at 12 and 24 months follow up by
IPTp group.
Neurodevelopment measures Three-dose SP Three-dose DP Monthly DP P
N=94 N=87 N=91
At 12 months
Cognitive ability, mean (sd) 10.63 (2.15) 10.74 (2.73) 11.01 (2.58) 0.560
Expressive language, mean (sd) 11.46 (1.64) 11.59 (1.90) 11.55 (1.49) 0.867
Receptive language, mean (sd) 8.40 (2.43) 8.95 (2.10) 8.36 (2.09) 0.142
Fine motor, mean (sd) 11.59 (2.52) 11.05 (2.79) 11.56 (2.81) 0.326
Gross motor, mean (sd) 11.01 (1.89) 10.61 (2.69) 11.04 (2.00) 0.347
At 24 months N=86 N=82 N=83
Cognitive ability, mean (sd) 6.55 (1.75) 6.56 (1.81) 6.93 (1.37) 0.243
Expressive language, mean (sd) 8.28 (1.63) 8.22 (1.63) 8.20 (1.52) 0.950
Receptive language, mean (sd) 8.03 (2.12) 7.68 (2.10) 8.19 (2.16) 0.290
Fine motor, mean (sd) 9.15 (1.48) 9.01 (1.64) 9.17 (1.91) 0.807
Gross motor, mean (sd) 9.13 (2.57) 8.71 (2.78) 9.47 (2.89) 0.205
DP, Dihydroartemisinin-Piperaquine; sd, Standard deviation; SP, Sulfadoxine-
Pyrimethamine.
4.4.2 Effects of malaria prophylaxis on mediators and
mediator effects on neurodevelopment outcomes
We regressed each mediator on IPTp to test their association. Compared to
three-dose SP, three-dose DP was protective against maternal malaria (P =
0.01), placental malaria (P = 0.04), and child malaria until 24 months (P =
0.04). On the other hand, compared to three-dose SP, monthly DP was pro-
tective against maternal malaria (P < 0.01) and placental malaria (P < 0.01)
(supplementary materials C.1).
We tested the effect of each mediator (maternal malaria, placental malaria,
adverse birth outcomes, cord blood hemoglobin, and child malaria) on each
ND outcome (cognitive ability, expressive language, receptive language, fine
motor, and gross motor). At 12 months, no mediator was associated with
any ND outcome measure. At 24 months, having an adverse birth outcome
was associated with lower child scores in expressive language (P = 0.01) and
fine motor (P = 0.02). Other associations did not reach statistical significance
(supplementary materials C.2).
56
4.4.3 Mediation effects of maternal malaria prophylaxis
on child neurodevelopment outcomes
We estimated the effect of three-dose DP or monthly DP on the five ND
outcome measures mediated by each potential mediator (maternal malaria,
placental malaria, adverse birth outcomes, cord blood hemoglobin, and child
malaria). The IE of IPTp on a ND outcome would be the change in ND re-
sulting from IPTp’s effect on the mediator.
At 12 months, placental malaria mediated the effect of three-dose DP (com-
pared to three-dose SP) on cognitive ability (Effect = 0.87, 95% CI 0.20, 1.54),
and the effect of monthly DP on expressive language (Effect = -0.50, 95% CI
-1.06, -0.05). The positive mediation effect suggests that on average, a child’s
cognitive ability improves by 0.87 as a result of three-dose DP’s effect on
placental malaria during pregnancy compared to three-dose SP, while the neg-
ative mediation effect suggests that on average, a child’s expressive language
declines by -0.50 as a result of monthly DP’s effect on placental malaria. Ma-
ternal malaria mediated the effect of three-dose DP on expressive language
(Effect = -1.28, 95% CI -1.95, -0.67). Maternal malaria, placental malaria,
adverse birth outcomes, or cord blood hemoglobin did not mediate the effects
of three-dose DP or monthly DP on receptive language, fine motor and gross
motor (Figure 4.2).
At 24 months, maternal malaria mediated the effect of three-dose DP (com-
pared to three-dose SP) on fine motor (Effect = 0.79, 95% CI 0.15, 1.56) and
placental malaria mediated the effect of three-dose DP on expressive language
(Effect = 0.68, 95% CI 0.19, 1.20) and receptive language (Effect = 0.76, 95%
CI 0.19, 1.48). Adverse birth outcomes mediated the effect of three-dose DP
on expressive language (Effect = 0.77, 95% CI 0.24, 1.33), receptive language
(Effect = 0.89, 95% CI 0.18, 1.64), and fine motor (Effect = 0.60, 95% CI 0.10,
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1.11). Cord blood hemoglobin and child malaria did not mediate the effects
of three-dose DP or monthly DP on all ND outcomes at 24 months (Figure
4.3). We also estimated mediation effects of any maternal malaria, a binary
variable that combined maternal malaria and placental malaria into one medi-
ator. Any maternal malaria mediated the effect of three-dose DP on cognitive
ability (Effect = 0.62, 95% CI 0.04, 1.27) at 12 months, and on expressive
language (Effect = 0.39, 95% CI 0.00, 0.83) and receptive language (Effect =
0.55, 95% CI 0.07, 1.12) at 24 months (Figure 4.4). Results in Figures 4.2,
4.3, and 4.4 are also presented in tables in supplementary materials C.3, C.3,
and C.4 respectively.
We concurrently estimated the mediation effects of any maternal malaria and
child malaria on the effect of mother-child prophylaxis combinations on ND
outcomes. At 24 months, compared to mother three-dose SP followed by child
three-monthly DP, we found that child malaria mediated the effect of mother
three-dose DP followed by child monthly DP on expressive language (Effect
= 0.15, 95% CI 0.01, 0.31). Child malaria also mediated the effect of mother
monthly DP followed by child monthly DP on expressive language (Effect =
0.12, 95% CI 0.01, 0.26). Any maternal malaria mediation effects of mother-
child prophylaxis on all ND outcomes did not reach statistical significance.
Mediation effects of mother-child prophylaxis through both mediators (any
maternal malaria and child malaria) on all ND outcomes were all approxi-
mately zero and did not reach statistical significance (Table 4.4).
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Figure 4.2 Mediator indirect effects of maternal malaria prophylaxis in pregnancy on 12-month neurodevelopment outcomes
among children whose mothers received either three-dose Dihydroartenisinin-piperaquine (DP) or monthly DP groups. Indirect
effects bars are 95% percentile bootstrap confidence intervals of 1000 samples.
59
Figure 4.3 Mediator indirect effects of maternal malaria prophylaxis in pregnancy on 24-month neurodevelopment outcomes
among children whose mothers received either three-dose Dihydroartenisinin-piperaquine (DP) or monthly DP groups. Indirect
effects bars are 95% percentile bootstrap confidence intervals of 1000 samples.
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Figure 4.4 The effect of maternal malaria prophylaxis in pregnancy on 12- and 24-month neurodevelopment outcomes among
children whose mothers received either three-dose dihydroartenisinin-piperaquine (DP) or monthly DP groups mediated by any
malaria (maternal or placental malaria or both). Indirect effects bars are 95% percentile bootstrap confidence intervals of 1000
samples.
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Table 4.4 The effect of maternal and child malaria prophylaxis combinations
on child neurodevelopment outcomes at 24 months mediated by any maternal
malaria (M1) and child malaria (M2).
Prophylaxis combination Through only M1 Through only M2 Through both M1 and M2 Total IE
Effect (95% CI) Effect (95% CI) Effect (95% CI) Effect (95% CI)
Cognitive ability
Mom 3DP, child 3DP 0.02 (-0.09, 0.13) 0.00 (-0.07, 0.06) 0.00 (-0.01, 0.01) 0.01 (-0.12, 0.13)
Mom 3DP, child MDP 0.01 (-0.05, 0.08) 0.03 (-0.13, 0.20) 0 (0, 0) 0.04 (-0.12, 0.02)
Mom MDP, child 3DP 0.02 (-0.11, 0.16) -0.01 (-0.10, 0.06) 0.00 (-0.02, 0.02) 0.01 (-0.14, 0.17)
Mom MDP, child MDP 0.02 (-0.09, 0.14) 0.03 (-0.11, 0.16) 0 (0, 0) 0.04 (-0.12, 0.20)
Expressive language
Mom 3DP, child 3DP 0.01 (-0.08, 0.12) -0.02 (-0.14, 0.08) 0.00 (-0.02, 0.03) -0.01 (-0.16, 0.13)
Mom 3DP, child MDP 0.00 (-0.05, 0.08) 0.15 (0.01, 0.31)* 0 (0, 0) 0.15 (0.01, 0.32)*
Mom MDP, child 3DP 0.01 (-0.10, 0.14) -0.05 (-0.18, 0.05) 0.00 (-0.02, 0.04) -0.03 (-0.20, 0.13)
Mom MDP, child MDP 0.01 (-0.08, 0.12) 0.12 (0.01, 0.26)* 0.00 (-0.01, 0.01) 0.13 (-0.02, 0.29)
Receptive language
Mom 3DP, child 3DP 0.04 (-0.08, 0.20) -0.01 (-0.09, 0.08) 0.00 (-0.02, 0.01) 0.04 (-0.10, 0.20)
Mom 3DP, child MDP 0.02 (-0.04, 0.13) 0.05 (-0.14, 0.25) 0 (0, 0) 0.07 (-0.13, 0.29)
Mom MDP, child 3DP 0.05 (-0.08, 0.24) -0.02 (-0.13, 0.06) 0.00 (-0.02, 0.02) 0.04 (-0.13, 0.23)
Mom MDP, child MDP 0.05 (-0.08, 0.20) 0.04 (-0.11, 0.2) 0.00 (-0.01, 0.01) 0.09 (-0.11, 0.30)
Fine motor
Mom 3DP, child 3DP 0.03 (-0.06, 0.14) 0.00 (-0.07, 0.05) 0.00 (-0.01, 0.01) 0.03 (-0.08, 0.15)
Mom 3DP, child MDP 0.02 (-0.03, 0.09) 0.01 (-0.14, 0.17) 0 (0, 0) 0.03 (-0.14, 0.20)
Mom MDP, child 3DP 0.04 (-0.08, 0.18) 0.00 (-0.09, 0.06) 0.00 (-0.01, 0.02) 0.03 (-0.10, 0.17)
Mom MDP, child MDP 0.03 (-0.06, 0.15) 0.01 (-0.11, 0.14) 0 (0, 0) 0.04 (-0.12, 0.22)
Gross motor
Mom 3DP, child 3DP -0.01 (-0.21, 0.17) -0.02 (-0.21, 0.12) 0.00 (-0.02, 0.04) -0.03 (-0.28, 0.20)
Mom 3DP, child MDP 0.00 (-0.14, 0.10) 0.18 (-0.07, 0.43) 0 (0, 0) 0.17 (-0.09, 0.45)
Mom MDP, child 3DP -0.01 (-0.24, 0.21) -0.06 (-0.25, 0.07) 0.00 (-0.03, 0.05) -0.06 (-0.35, 0.19)
Mom MDP, child MDP -0.01 (-0.21, 0.16) 0.14 (-0.05, 0.38) 0.00 (-0.01, 0.01) 0.13 (-0.13, 0.39)
Reference: Mom three-dose sulfadoxine-pyrimethamine (SP), child three-dose
dihydroartenisinin-piperaquine (DP); CI, 95% percentile confidence interval
from 1000 bootstrap samples; IE, Indirect effect; 3DP, Three-dose DP; MDP,
Monthly DP.
*Significant i.e. 95% percentile confidence interval excludes the null (zero).
4.5 Discussion
In this randomized, double-blinded, controlled trial of malaria prophylaxis dur-
ing pregnancy, we sought to establish indirect (mediated) effects of potential
mediators of IPTp effects on a child’s ND at 12 and 24 months. Potential
mediators of IPTp’s effect on child ND included maternal malaria, placental
malaria, adverse birth outcomes, cord blood hemoglobin, and child malaria.
We found that placental malaria mediated the effect of three-dose DP on
cognitive ability at 12 months, and on expressive and receptive language at
24 months. We did not find significant indirect effects of three-dose DP or
62
monthly DP on ND outcomes through cord blood hemoglobin or child malaria
at 24 months. When we combined placental malaria and maternal malaria
into one mediator, any maternal malaria, we found that any maternal malaria
mediated the effect of three-dose DP on cognitive ability at 12 months and
on expressive and receptive language at 24 months. In this study, pregnant
women randomized to either three-dose DP or monthly DP had significantly
fewer episodes of malaria during pregnancy. Malaria infection if untreated
can lead to placental malaria (PM) (Rogerson et al., 2007). Placental malaria
was measured at birth and its presence may not only reflect current malaria
infections but also infections one month preceding delivery (Rogerson et al.,
2007). In fact, there were mothers diagnosed with placental malaria at birth
but who were not diagnosed with malaria throughout their pregnancy. A pro-
posed mechanism for this is that placental malaria decreases placental blood
flow, and placental inflammation resulting from malaria infection impairs the
nutrition transport function of the placenta (Rogerson et al., 2007). These
placental infections affecting nutrient transport in the third trimester when
nutrients are in highest demand, have grave implications for fetal growth in-
cluding ND (Conroy et al., 2013; Scifres and Nelson, 2009). In addition, ma-
ternal immune response, in particular proinflammatory cytokines, are thought
to interfere with normal fetal brain development (Kronfol and Remick, 2000;
Nawa et al., 2000). Animal models have indicated that offspring exposed to
maternal infections in utero experience disruptions to normal neurodevelop-
ment including gene expression in the brain and impaired neurotransmitter
function (Golan et al., 2005; Meyer et al., 2006; Ozawa et al., 2006). It is
possible that the activation of maternal immune response affects ND, even
in the absence of fetus infection. It is therefore imperative to use efficacious
malaria intermittent preventive treatment during pregnancy to prevent detri-
mental effects of placental malaria on the unborn child. Unexpected findings
at 12 months were the negative monthly DP effect on expressive language me-
diated by placental malaria and a negative three-dose DP effect on expressive
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language mediated by maternal malaria. However, these findings did not per-
sist at 24 months follow up. Although substantial progress has been made
to develop antimalarials that are efficacious with less side effects, older anti-
malarials of the quinoline class have been associated with psychiatric effects
(Nevin and Croft, 2016). It is unclear if this is also the case for artemisinin-
based combination therapies (ACTs) (Ramos-Mart´ın et al., 2014), specifically
affecting expressive language, but this certainly warrants further investigation.
When children were born, they were randomly assigned to receive either three-
dose DP or monthly DP between 2-24 months. A study in Gambia followed
children who had been randomized to malaria prophylaxis and placebo at
age 3-59 months and measured their neurocognition at 14-20 years of age.
Investigators found no significant differences in attention, memory, reason,
knowledge and language (Jukes et al., 2006). A limitation in their study was
that after the first trial, all children were offered malaria prevention with dap-
sone/pyremethamine, making it difficult to detect malaria prevention effects
over 14 years later. In this study, significant mediated effects of IPTp with
three-dose DP were observed after adjusting for the child’s malaria chemo-
preventive prophylaxis. Mediation effects of placental malaria on the effect
three-dose DP on cognitive ability, receptive language, and receptive language
indicate potential early benefits of IPTp at a critical time of infant brain devel-
opment. However, further studies are required to understand mediated effects
and interactions between maternal and child chemopreventive malaria prophy-
laxis on child ND outcomes.
We also found that adverse birth outcomes mediated the effect of three-dose
DP on expressive language, receptive language, and fine motor. We hypothe-
sized that the protective effect of three-dose DP or monthly DP against malaria
compared to three-dose SP could prevent adverse birth outcomes and conse-
quently lead to better ND outcomes. Findings from the same cohort as the
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current study have shown that IPTp with DP significantly reduces parasite
prevalence and the risk of placental malaria (Kakuru et al., 2016). A study that
used indoor residual spraying of insecticide (IRS) to prevent malaria during
pregnancy found that IRS significantly reduced malaria incidence and women
with IRS protection had a lower prevalence of placental parasitaemia, lower
risk of LBW, preterm birth and fetal or neonatal deaths (Muhindo et al., 2016).
Interventions that lower the incidence of maternal or placental malaria may
lower the incidence of adverse birth outcomes. In fact, children whose mothers
were randomized to three-dose DP had a lower prevalence of adverse birth out-
comes compared to those randomized to three-dose SP. These findings together
with another study that found an elevated risk of neurocognitive impairment
among SGA infants (Shah et al., 2011), suggest a potential improvement of
child ND outcomes as a result IPTp with DP’s effect on adverse birth out-
comes. Although studies have associated maternal and placental malaria with
low birth weight and preterm birth (Desai et al., 2007; Kapisi et al., 2017;
Kasumba et al., 2000; Menendez et al., 2000), malaria in pregnancy only ac-
counts for 20% of LBW (Desai et al., 2007). Causes of preterm birth have
been found to include genetic influence, stress, smoking, alcohol consumption,
poor nutrition status, intrauterine infection, and non-genital tract infections
(Piso et al., 2014). In addition, successful interventions against malaria have
not all registered improvements in birth outcomes (Desai et al., 2016; Ndy-
omugyenyi et al., 2011). However, it is possible that prevention of maternal
malaria or placental malaria during pregnancy using three-dose DP prophy-
laxis contributed to improved birth outcomes.
The efficacy of the WHO-recommended and widely-used IPTp with SP (WHO,
2017) has recently gained attention. Studies among infants found that IPT
with SP had no protective efficacy against malaria and was associated with
an increased risk of moderate to severe malaria (Bigira et al., 2014; Gosling
et al., 2009). In pregnant women, a study that compared the effectiveness
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on IPTp with SP, insecticide-treated nets (ITNs), and a combination of ITNs
and IPTp with SP found no differences between interventions in low birth
weight, prevalence of maternal anemia (hemoglobin < 11.0 g/dl), prevalence
of peripheral parasitemia, and no difference in placental parasitemia among
women who delivered at a health unit (Ndyomugyenyi et al., 2011). In the
current study, findings of elevated episodes of malaria and an increased risk
of placental malaria among pregnant women who received IPTp with SP are
consistent with observed resistance to IPT with SP among pregnant women
in western Kenya (Iriemenam et al., 2012). On the other hand, a study con-
ducted among school children in the same region as our study found that
IPTp with DP protected children against clinical malaria, parasitemia, and
anemia (Nankabirwa et al., 2014). DP provides rapid killing of parasites by
dihydroartemisinin and piperaquine provides prolonged protection against any
remaining parasites (Nankabirwa et al., 2016). The long period of protection
DP provides due to the long half-life of piperaquine (Hoglund et al., 2012;
Nankabirwa et al., 2016; Tarning et al., 2008) protects against any placental
malaria (Kakuru et al., 2016) and thus could prevent any delays in a child’s
ND. Therefore, the waning efficacy of IPT with SP irrespective of level of
malaria transmission (Iriemenam et al., 2012; Ndyomugyenyi et al., 2011) in
part explains these results.
We also found that cord blood hemoglobin did not mediate the effects of three-
dose DP or monthly DP IPTp on child ND. Monthly IPT with DP in children
improves hemoglobin levels and reduces the risk of anemia (Boivin et al., 2016;
Nankabirwa et al., 2014). However, studies conducted among pregnant women
and infants found that IPT with SP increased the risk of anemia in mothers
and children (Bigira et al., 2014; Gosling et al., 2009; Harrington et al., 2011).
Iron is essential in a child’s development and deficiencies in the early stages
of life could affect their ND (Lozoff et al., 1998; Nelson et al., 2001; Okoko
et al., 2003). In the current study, the proportion of maternal anemia at birth
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and the prevalence of cord blood hemoglobin below 11.0 g/dl was equally dis-
tributed among IPTp groups. A study in Ugandan children found anemia to
mediate the effect of malaria on cognition (Boivin et al., 2016). However, after
treatment cessation, no differences were seen in episodes of anemia between
children on IPT with DP and IPT with SP (Boivin et al., 2016). It is possible
that malaria infection effects such as maternal anemia were resolved by IPTp
early during pregnancy before birth.
Maternal nutrition during pregnancy is a major determinant of birth weight,
and nutritional supplementation has been shown to improve birth outcomes
(Ceesay et al., 1997). In this study we did not measure maternal nutrition
status throughout pregnancy. However, a strength of this study is that IPTp
was randomized, and therefore we judge that non-measurement of nutritional
status during pregnancy would not alter the study results.
Prevention of malaria during pregnancy remains a major public health in-
tervention in protecting unborn children against placental malaria, which may
impact children’s ND. Even in the absence of peripheral parasitemia, when in-
fection may be undetectable by blood smears, IPTp remains central to clearing
placental parasitemia.
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Chapter 5
Conclusion and future work
5.1 Conclusion
In longitudinal studies, understanding mechanisms by which an exposure or
treatment affects an outcome in mediation analysis can be complicated by
measurement error and missing data. This dissertation has explored the ef-
fects of missing data and measurement error in longitudinal studies in the
context of mediation analysis.
In Chapter 2, we presented the counterfactual framework for mediation anal-
ysis in longitudinal studies when a repeatedly measured mediator is measured
with error. The assumption of no unmeasured confounders is necessary to
identify the direct and indirect effects. Appendices A.2.1 and A.2.2 illustrate
how one can check on these assumptions in real practice. We found that
when the mediator is repeatedly measured with error, regression calibration
improves mediation effect estimates in comparison to no calibration. For the
scenarios considered, assuming normality for the random effects in regression
calibration provides approximately unbiased estimators regardless of the true
distribution of the random effects.
In Chapter 3, we presented the effects of misspecification of the imputation
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model in longitudinal studies, specifically ignoring clustering by subject, on
mediated effects when the mediator and outcome are partly missing. We com-
pared complete case analysis, an LM imputation method, an approach that
ignores clustering by subject in the imputation model, and an MCMC ap-
proach that considers clustering, according to bias, MSE, and coverage prob-
ability when data was MCAR or MAR. We found that for moderate amounts
of missing data, considering clustering in the multiple imputation model gives
approximately unbiased mediation estimators unlike the other approaches.
In Chapter 4, we investigated the mediation effects of IPTp on child ND
outcomes in a randomized clinical trial. We found that placental malaria me-
diates the effect of three-dose DP prophylaxis on child cognitive ability at 12
months and on child expressive and receptive language at 24 months. These
findings suggest benefits of IPTp with DP in averting potential detrimental
placental malaria effects on child ND.
5.2 Future Work
Chapter 2’s simulations considered models with only a random intercept. Mc-
Culloch and Neuhaus (2011) points out that when the mean of the random
effects distribution depends on a covariate, a relationship between the covari-
ate and the random effect distribution is introduced, creating a serious bias
in estimating the relationship between the covariate and the outcome. We
did not examine this scenario, and the potential effects of this relationship
on the estimation of ACME and ADE need to be investigated further. We
assumed that the residual error in the mediator and outcome models were un-
correlated. In a smaller simulation study (appendix A.4), we observed that as
the mediator-outcome correlation increases, with an increase in within subject
variability, the ACME and ADE estimates are more biased. More research
towards relaxing the independence assumption or developing a bias correction
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approach is needed, especially when mediator and outcome are correlated.
Chapter 3 considered missing data mechanisms in a time-varying continuous
mediator and outcome. The MAR mechanism depended on the magnitude
of time-point to time-point reduction in either the mediator or outcome mea-
sures. Investigation of other MAR mechanisms, such as MAR mechanisms
that depend on auxiliary variables, may offer improvements when auxiliary
variables are included in the imputation model.
In Chapter 4, we did not find significant any maternal malaria mediation ef-
fects or mediation effects through both any maternal malaria and child malaria
(Table 4.4). Splitting the exposure groups into mother-child prophylaxis com-
binations made group sizes small and this may have affected the power to
detect mediation effects. Larger studies with sufficient power would help to
estimate mediated effects of combinations of mother-child prophylaxis on the
child’s neurodevelopment.
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Appendix A
Chapter 2 Appendix
A.1 Time-varying ACME and ADE derivation
Assume that Yij is the outcome for subject i at time j = 1, 2, . . . , s, Mij is
a continuous mediator repeatedly measured with error, Xi is the binary ex-
posure/treatment variable (1=Treatment, 0=Control) but can be continuous,
Gi is a baseline covariate, Cij is a mediator-outcome confounder, and tj is the
time indicator i.e. tj = I(t = j). The derivation assumes the data genera-
tion mechanism for the binary exposure coefficient in the mediator calibration
model is fixed.
Yij = u
Y ∗
0i + β0 + βxXi + βt2t2 + · · ·+ βtsts + βgGi + βcCij + eij (A.1)
Yij = u
Y
0i + γ0 + γxXi + γmM
∗
ij + γxmXiM
∗
ij + γt2t2 + · · ·+ γtsts
+ γgGi + γcCij + rij (A.2)
Mij = u
M
0i + ζ0 + ζxXi + ζt2Xit2 + · · ·+ ζtsXits + ζgGi + ij (A.3)
where eij ∼ N(0, σ2e), ij ∼ N(0, σ2 ), rij ∼ N(0, σ2r), uY ∗0i ∼ N(0, σ2uY ∗i ), u
Y
0i ∼
N(0, σ2
uYi
) and uM0i ∼ N(0, σ2uMi ); eij is independent of u
Y ∗
0i , ij is independent
of uM0i , rij is independent of u
Y
0i, u
M
0i is independent of u
Y
0i, ij and rij are
independent, and M∗ij = u
M
0i + ζ0 + ζxXi + ζt2Xit2 + · · · + ζtsXits + ζgGi is
the mediator measured without error. The total effect is given by βx in model
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(A.1). Using model (A.2), for values x, x˜, x′ of Xi and the calibrated mediator
M̂∗ij, the direct effect (ADE) is given by
ADEj = E
{
Yj(x,M
∗
j (x
′))− Yj(x˜,M∗j (x′)) | Gi = gi, Cij = cij, tj
}
= (γx + γxmm
∗
ij)(x− x˜)
Using equations (A.2) and (A.3) and the product method (Baron and Kenny,
1986), the time-varying average causal mediation effect (indirect effect) is given
by
ACMEj = E
{
Yj(x
′,M∗j (x))− Yj(x′,M∗j (x˜)) | Gi = gi, Cij = cij, tj
}
= γ0 + γxx
′ + γm
{
ζ0 + ζxx+ ζtjx
}
+ γxmx
′{ζ0 + ζxx+ ζtjx}
− γ0 − γxx′ − γm
{
ζ0 + ζxx˜+ ζtj x˜
}− γxmx′{ζ0 + ζxx˜+ ζtj x˜}
= γm
{
ζx + ζtj
}
(x− x˜) + γxmx′
{
ζx + ζtj
}
(x− x˜)
Assuming x = 1 and x˜ = 0, then
ACMEj = γmζx + γmζtj + γxmζxx
′ + γxmx′ζtj
where x′ can take on values 0 or 1. When there is no exposure-mediator
interaction in the outcome model (A.2) but there is exposure-time interaction
in the mediator model (A.3), then ACME at time j is given by
ACMEj = γmζx + γmζtj
When there is exposure-mediator interaction in the outcome model (A.2) but
no exposure-time interaction in the mediator model (A.3), then ACME at time
j is given by
ACMEj = γmζx + γxmζtj
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When there is no interaction in the outcome model (A.2) and mediator model
(A.3),
ACMEj = γmζx
A.2 Checking identification assumptions for
data application examples.
Identification assumptions were checked using subject matter knowledge. Us-
ing directed acyclic graphs (DAG), we assessed whether a covariate was a
confounder or not. The assumption of no mediator-outcome confounder as-
sociated with the exposure was assessed using both subject knowledge and
empirically.
A.2.1 Severe malaria and cognition data
(i) Exposure-mediator confounder was: Any child education.
(ii) Exposure-outcome confounders were: Age and any child education.
(iii) Mediator-outcome confounders were: Age and any child education.
(iv) No mediator-outcome confounders associated with the exposure: The
exposure (malaria group) was regressed on baseline age and then on any
child education. The p-values were 0.410 and 0.477 for baseline age and
any child education respectively.
(v) No time-varying confounding with respect to the mediator: Since the
exposure group (malaria group) for each subject is fixed throughout the
study, we do not expect the mediator (hemoglobin level) at time j to
affect the exposure at time j + 1. We also judge that the cognitive
outcome at time j does not affect the mediator (hemoglobin level) at
time j + 1.
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A.2.2 HIV-LIVE (Longitudinal Interrelationships of
Viruses and Ethanol) data
(i) Exposure-mediator confounders were: Literacy score, baseline age, and
HIV quality of life scale.
(ii) Exposure-outcome confounders were: Baseline age, homeless in the last
6 months, and HIV quality of life scale.
(iii) Mediator-outcome confounders were: Homeless in the last 6 months and
HIV quality of life scale.
(iv) No mediator-outcome confounders associated with the exposure: First,
the exposure (at risk of drinking) was regressed on HIV quality of life at
the 6 time points (1, 3, 5, 6, 7, 8) and p-values were 0.996, 0.453, 0.614,
0.201, 0.092, 0.049 respectively. Second, the exposure was regressed on
homeless status in the last 6 months at the 6 time points (1, 3, 5, 6, 7,
8) and p-values were 0.214, 0.545, 0.918, 0.390, 0.564, 0.161 respectively.
(v) Time-varying confounding with respect to the mediator: In this anal-
ysis, the exposure status for a subject throughout followup is fixed at
baseline. We do not expect the mediator at time j to affect the exposure
of any subject at subsequent time points. We acknowledge that if the
exposure is time-varying, which is a more likely and practical behavior
by study subjects during followup, this assumption can be violated. It
is also possible that the outcome (CD4) at time j affects the mediator
(adherence) at subsequent time points.
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A.3 Simulation results with only three (3) time
points.
Results from this simulation with three time points are very similar to the
simulation results with six time points (Table A.1). Though the mean square
errors under the different mediator random effect distribution assumptions are
slightly higher than when there were six time points, they are similar within
distribution assumption for normal calibration and SNP calibration (Table
A.2).
Table A.1 Simulation results: average causal mediation effect (ACME) and
average direct effect (ADE) estimates either assuming normality or SNP ap-
proach for the random effects in the mediator calibration model for three time
points.
Average causal mediation effect (ACME)
Distribution of RE Normal calibration model SNP calibration model Using mediator with error
Estimate Bias MSE Estimate Bias MSE Estimate Bias MSE
(-1.360) (-1.360) (-1.360)
Normal -1.361 -0.001 0.021 -1.361 -0.001 0.021 -0.501 0.859 0.742
χ2(4) -1.358 0.002 0.035 -1.358 0.002 0.035 -0.778 0.582 0.354
Mixture of Normals -1.363 -0.003 0.025 -1.365 -0.005 0.025 -0.551 0.809 0.661
Average direct effect (ADE)
Estimate Bias MSE Estimate Bias MSE Estimate Bias MSE
(-0.600) (-0.600) (-0.600)
Normal -0.604 -0.004 0.014 -0.604 -0.004 0.014 -1.463 -0.863 0.763
χ2(4) -0.603 -0.003 0.012 -0.603 -0.003 0.012 -1.183 -0.583 0.360
Mixture of Normals -0.602 -0.002 0.014 -0.601 -0.001 0.014 -1.414 -0.814 0.683
RE, Random effects; MSE, Mean square error; SNP, Seminonparametric
approach. Number Monte-Carlo data sets = 2000.
Table A.2 Simulation results: mean square errors and standard deviation
comparing true random effects distribution and estimated random effects dis-
tribution assuming normality or using the SNP approach for three time points.
Distribution of Random effects Normal χ24 Mixture of Normals
MSE SD MSE SD MSE SD
Normal calibration 0.456 0.030 0.495 0.037 0.466 0.031
SNP calibration 0.459 0.034 0.490 0.054 0.456 0.052
RE, Random effects; MSE, Mean square error; SD, Standard deviation. The
mediator and outcome are independent. Number of Monte-Carlo data sets =
2000.
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A.4 Simulation results when the outcome and
mediator are correlated
This simulation focused on when the mediator model random effects are nor-
mally distributed. Its objective was to investigate changes in the ACME and
ADE at different levels of intra-class correlation (ICC) and at different levels
of mediator-outcome correlations. The model assumptions were the same as
the simulation in the paper except that Cov(Yij , Mij) was varied to (0, 0.3062,
0.6124, 0.9798), inducing mediator-outcome correlations (0, 0.25, 0.5, 0.8) re-
spectively. Also, the mediator random effect variance was varied such that
bM0i ∼ N(0, σ2bM ), where σ2bM = (0.25, 1.00, 2.25, 4.00, 6.25, 9.00, 16.00, 25.00), so
that the ICC changes for each σ2bM to (0.14, 0.40, 0.60, 0.73, 0.81, 0.86, 0.91,
0.94) respectively. This yielded 32 different scenarios and 300 Monte-Carlo
data sets were generated for each scenario. Results are displayed in Figure
A.1.
Results from this smaller simulation show that as within subject variability be-
comes small relative to between subject variability, the estimates (ACME and
ADE) tend towards their true values irrespective of the mediator-outcome cor-
relation. When within subject variability is large relative to between subject
variability, higher mediator outcome correlations indicated higher deviation
of estimates from their true values. More research towards bias correction in
estimates is needed, especially when mediator and outcome are correlated.
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Figure A.1 ACME and ADE estimate averages by intraclass correlation
with differing mediator-outcome correlation (rho). Number of Monte-Carlo
data sets per average = 300.
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Appendix B
Chapter 3 Appendix
B.1 Mediator difference and then impute ap-
proach
In this simulation, instead of imputing missing data for the outcome Yij and
mediator Mij, the deviation from the baseline mediator value (Mij −Mi1) at
each time point was first calculated before imputation. If the mediator was
missing at a time point, Mij −Mi1 was missing too at that time point. The
outcome and Mij − Mi1 were then imputed ignoring clustering, considering
clustering, and using the linear model (LM). 2000 complete datasets were
generated and data was set to missing according to missing completely at
random (MCAR) and missing at random (MAR) for each data set, at rates
of 10%, 20%, 30% and 40%. 10 data sets were imputed for missing values
in each data set using the three methods, ACME and ADE estimated and
pooled. Comparisons of the methods on bias, mean square error, mean Sobel
standard error (MS-SE), and the coverage probability for the true values were
similar with results when the mediator was imputed first and the deviation
from baseline computed afterwards.
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Table B.1 Simulation results: average causal mediation effect (ACME) estimates when no imputation is conducted and after
multiple imputation using different approaches in longitudinal data for differing proportions of missing data. Computing the
mediator difference first, followed by multiple imputation.
Prop. Method Missing completely at random (MCAR) Missing at random (MAR)
Estimate Bias MSE MC-SD MS-SE CP Estimate Bias MSE MC-SD MS-SE CP
Complete -2.17 -0.01 0.17 0.41 0.40 0.95 -2.17 -0.01 0.17 0.41 0.40 0.95
10% No imputation -2.17 -0.01 0.19 0.43 0.42 0.94 -2.25 -0.09 0.19 0.43 0.42 0.94
IC -2.19 -0.03 0.19 0.44 0.42 0.94 -2.26 -0.10 0.20 0.44 0.42 0.94
LM -2.15 0.01 0.19 0.43 0.42 0.94 -2.24 -0.08 0.19 0.43 0.42 0.95
CC -2.17 -0.01 0.18 0.43 0.41 0.94 -2.21 -0.05 0.18 0.42 0.41 0.95
20% No imputation -2.17 -0.01 0.20 0.44 0.45 0.95 -2.30 -0.14 0.22 0.45 0.45 0.95
IC -2.23 -0.07 0.22 0.46 0.45 0.94 -2.32 -0.16 0.24 0.46 0.45 0.94
LM -2.14 0.02 0.20 0.45 0.45 0.95 -2.27 -0.11 0.21 0.45 0.45 0.95
CC -2.17 -0.01 0.19 0.43 0.43 0.94 -2.23 -0.07 0.19 0.43 0.43 0.95
30% No imputation -2.16 -0.00 0.24 0.49 0.48 0.95 -2.34 -0.18 0.28 0.49 0.49 0.93
IC -2.28 -0.12 0.28 0.52 0.48 0.92 -2.39 -0.23 0.33 0.52 0.49 0.90
LM -2.11 0.05 0.24 0.49 0.48 0.94 -2.29 -0.13 0.26 0.49 0.48 0.94
CC -2.17 -0.01 0.22 0.47 0.44 0.94 -2.25 -0.09 0.23 0.47 0.45 0.93
40% No imputation -2.17 -0.01 0.28 0.53 0.52 0.95 -2.37 -0.21 0.33 0.53 0.53 0.94
IC -2.34 -0.18 0.36 0.58 0.51 0.90 -2.47 -0.31 0.43 0.58 0.53 0.89
LM -2.09 0.07 0.29 0.53 0.51 0.93 -2.27 -0.11 0.30 0.53 0.52 0.93
CC -2.17 -0.01 0.25 0.50 0.46 0.93 -2.27 -0.11 0.26 0.50 0.48 0.94
CC, Considering clustering; CP, Coverage probability; IC, Ignoring clustering; LM, Linear model; MC-SD, Monte-Carlo standard
deviation; MSE, Mean square error; MS-SE, Mean Sobel standard error; Prop, Proportion of missing data. True ACME =
-2.16, sample size = 300, and number of Monte-Carlo data sets = 2000.
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Table B.2 Simulation results: average direct effect (ADE) estimates when no imputation is conducted and after multiple
imputation using different approaches in longitudinal data for differing proportions of missing data. Computing the mediator
difference first, followed by multiple imputation.
Prop. Method Missing completely at random (MCAR) Missing at random (MAR)
Estimate Bias MSE MC-SD Avg-SE CP Estimate Bias MSE MC-SD Avg-SE CP
Complete -1.50 0.00 0.07 0.27 0.27 0.96 -1.50 0.00 0.07 0.27 0.27 0.96
10% No imputation -1.51 -0.01 0.08 0.29 0.29 0.95 -1.37 0.13 0.10 0.28 0.28 0.93
IC -1.51 -0.01 0.08 0.29 0.29 0.95 -1.37 0.13 0.10 0.28 0.28 0.93
LM -1.51 -0.01 0.08 0.29 0.29 0.95 -1.37 0.13 0.10 0.28 0.28 0.93
CC -1.51 -0.01 0.08 0.27 0.28 0.95 -1.51 -0.01 0.08 0.28 0.28 0.95
20% No imputation -1.51 -0.01 0.09 0.30 0.31 0.96 -1.29 0.21 0.13 0.29 0.29 0.88
IC -1.51 -0.01 0.09 0.30 0.31 0.96 -1.29 0.21 0.13 0.29 0.30 0.89
LM -1.51 -0.01 0.09 0.30 0.31 0.95 -1.29 0.21 0.13 0.30 0.30 0.89
CC -1.51 -0.01 0.08 0.28 0.28 0.95 -1.50 0.00 0.08 0.28 0.29 0.95
30% No imputation -1.50 0.00 0.11 0.33 0.33 0.94 -1.23 0.27 0.17 0.31 0.32 0.86
IC -1.50 0.00 0.11 0.33 0.33 0.94 -1.24 0.26 0.17 0.31 0.32 0.87
LM -1.50 0.00 0.11 0.34 0.33 0.94 -1.23 0.27 0.17 0.32 0.32 0.86
CC -1.50 0.00 0.08 0.29 0.29 0.95 -1.50 0.00 0.08 0.29 0.29 0.96
40% No imputation -1.51 -0.01 0.12 0.35 0.35 0.95 -1.16 0.34 0.23 0.35 0.34 0.82
IC -1.51 -0.01 0.12 0.35 0.36 0.95 -1.17 0.33 0.22 0.34 0.35 0.83
LM -1.51 -0.01 0.13 0.36 0.36 0.94 -1.17 0.33 0.24 0.36 0.35 0.82
CC -1.51 -0.01 0.09 0.29 0.30 0.95 -1.49 0.01 0.09 0.29 0.31 0.96
CC, Considering clustering; CP, Coverage probability; IC, Ignoring clustering; LM, Linear model; MC-SD, Monte-Carlo standard
deviation; MSE, Mean square error; Avg-SE, Average standard error; Prop, Proportion of missing data. True ADE = -1.50,
sample size = 300, and number of Monte-Carlo data sets = 2000.
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C.1 Effect of intermittent preventive treatment in pregnancy (IPTp) on
potential mediators
Table C.1 Effect of intermittent preventive treatment in pregnancy (IPTp) on different mediators (maternal malaria, placental
malaria, adverse birth outcomes, cord blood hemoglobin, and child malaria at 12 and 24 months).
Exposure Maternal malaria Placental malaria Adverse birth outcome Cord blood hemoglobin Child malaria at 12mo Child malaria at 24mo
Effect (SE) P Effect (SE) P Effect (SE) P Effect (SE) P Effect (SE) P Effect (SE) P
Three-dose DP -0.94 (0.37) 0.01 -0.64 (0.31) 0.04 -0.25 (0.32) 0.44 -0.63 (0.35) 0.07 -0.35 (0.66) 0.60 -0.78 (0.38) 0.04
Monthly DP -1.38 (0.40) <0.01 -1.02 (0.32) <0.01 -0.10 (0.31) 0.75 0.22 (0.34) 0.51 0.20 (0.58) 0.73 -0.37 (0.35) 0.28
Reference exposure group: Three-dose sulfadoxine-pyremethamine (SP); DP, Dihydroartenisinin-piperaquine; mo, Months.
To estimate the IPTp effects on mediators, we fitted a linear regression model for cord blood hemoglobin and logistic regression
models for the rest of the mediators with only IPTp as the predictor.
Effects are log odds ratios i.e. model coefficients.
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C.2 Effect of potential mediators on child neurodevelopment (ND) outcomes
at 12 and 24 months
Table C.2 Effect of mediators (maternal malaria, placental malaria, adverse birth outcome, and cord blood hemoglobin) on
neurodevelopment outcomes at 12 and 24 months.
Mediators Cognitive ability Expressive language Receptive language Fine motor Gross motor
Effect (SE) P Effect (SE) P Effect (SE) P Effect (SE) P Effect (SE) P
At 12 months
Maternal malaria 0.31 (0.38) 0.41 0.41 (0.25) 0.11 0.11 (0.34) 0.74 0.27 (0.41) 0.51 0.38 (0.33) 0.25
Placental malaria -0.17 (0.31) 0.58 0.03 (0.21) 0.88 -0.17 (0.28) 0.54 0.17 (0.34) 0.62 -0.01 (0.28) 0.97
Maternal or Placental malaria -0.16 (0.30) 0.59 0.03 (0.20) 0.88 -0.09 (0.27) 0.75 0.32 (0.33) 0.33 0.2 (0.27) 0.47
Adverse birth outcome -0.32 (0.32) 0.32 0.01 (0.22) 0.97 -0.15 (0.29) 0.61 -0.44 (0.35) 0.21 -0.51 (0.29) 0.08
Cord blood hemoglobin 0.04 (0.07) 0.56 -0.08 (0.05) 0.08 -0.05 (0.06) 0.39 0.07 (0.08) 0.33 -0.08 (0.06) 0.19
Child malaria -0.15 (0.62) 0.81 -0.31 (0.42) 0.46 -0.10 (0.56) 0.86 -0.56 (0.68) 0.41 -0.95 (0.55) 0.09
At 24 months
Maternal malaria -0.01 (0.26) 0.98 0.33 (0.25) 0.18 0.35 (0.33) 0.29 -0.26 (0.26) 0.32 -0.42 (0.43) 0.33
Placental malaria -0.29 (0.22) 0.18 -0.19 (0.20) 0.35 -0.45 (0.27) 0.10 -0.04 (0.22) 0.84 0.24 (0.36) 0.50
Maternal or Placental malaria -0.15 (0.21) 0.48 -0.05 (0.20) 0.82 -0.23 (0.27) 0.39 -0.13 (0.21) 0.54 -0.04 (0.35) 0.90
Adverse birth outcome -0.35 (0.23) 0.12 -0.55 (0.21) 0.01∗ -0.52 (0.29) 0.07 -0.55 (0.23) 0.02∗ -0.56 (0.37) 0.14
Cord blood hemoglobin 0.00 (0.05) 0.94 0.02 (0.04) 0.72 -0.06 (0.06) 0.35 0.02 (0.05) 0.73 -0.02 (0.08) 0.80
Child malaria 0.33 (0.37) 0.37 -0.32 (0.25) 0.19 0.14 (0.33) 0.68 -0.21 (0.4) 0.61 -0.39 (0.33) 0.23
SE, Standard error; ∗P < 0.05
To estimate the mediator effects on neurodevelopment outcomes, we fitted linear regression models with each mediator as the
only predictor.
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C.3 Mediation effects of intermittent preventive treatment in pregnancy on
neurodevelopment outcomes at 12 and 24 months (tabular form)
Table C.3 displays results for Figures 4.2 and 4.3 in tabular format.
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Table C.3 Mediation effects of maternal malaria prophylaxis on child neurodevelopment outcomes through different mediators
among children whose mothers received either three-dose DP or monthly DP.
Mediators Time point Prophylaxis Neurodevelopment outcome measures
Cognitive ability Expressive language Receptive language Fine motor Gross motor
Effect (95% CI) Effect (95% CI) Effect (95% CI) Effect (95% CI) Effect (95% CI)
Maternal malaria 12 Months 3 dose DP 0.10 (-1.12, 1.32) -1.28 (-1.95, -0.67)* 0.03 (-1.05, 1.28) -0.89 (-2.09, 0.27) -0.85 (-1.88, 0.29)
Monthly DP -0.52 (-2.58, 1.74) 0.52 (-0.22, 1.33) -0.43 (-1.55, 0.88) 0.88 (-0.90, 2.78) -0.73 (-1.83, 0.30)
24 Months 3 dose DP 0.52 (-0.58, 1.70) -0.38 (-1.30, 0.61) 0.11 (-0.88, 1.19) 0.79 (0.15, 1.56)* 1.00 (-0.06, 2.22)
Monthly DP -0.16 (-0.68, 0.46) 0.24 (-0.67, 1.23) 0.13 (-0.93, 1.28) 0.06 (-1.24, 1.56) 0.83 (-0.55, 2.04)
Placental malaria 12 Months 3 dose DP 0.87 (0.20, 1.54)* 0.42 (-0.17, 1.09) 0.44 (-0.14, 1.02) -0.19 (-0.99, 0.66) 0.51 (-0.29, 1.36)
Monthly DP -0.28 (-1.06, 0.53) -0.50 (-1.06, -0.05)* -0.42 (-1.19, 0.27) -0.31 (-1.26, 0.63) -0.62 (-1.32, 0.07)
24 Months 3 dose DP 0.45 (-0.11, 1.09) 0.68 (0.19, 1.20)* 0.76 (0.19, 1.48)* 0.40 (-0.05, 0.88) 0.05 (-0.88, 0.99)
Monthly DP 0.01 (-0.55, 0.56) -0.17 (-0.65, 0.29) 0.16 (-0.57, 0.86) -0.08 (-0.63, 0.48) -0.7 (-1.94, 0.33)
Adverse birth outcome 12 Months 3 dose DP 0.50 (-0.43, 1.46) 0.17 (-0.47, 0.93) 0.13 (-0.5, 0.75) 0.31 (-0.63, 1.26) 0.55 (-0.46, 1.69)
Monthly DP 0.31 (-0.46, 1.19) 0.06 (-0.41, 0.54) -0.04 (-0.69, 0.60) 0.28 (-0.65, 1.15) 0.25 (-0.43, 0.86)
24 Months 3 dose DP 0.50 (-0.07, 1.07) 0.77 (0.24, 1.33)* 0.89 (0.18, 1.64)* 0.60 (0.10, 1.11)* 0.18 (-0.92, 1.21)
Monthly DP 0.00 (-0.39, 0.41) -0.14 (-0.67, 0.35) -0.23 (-0.96, 0.47) 0.59 (-0.09, 1.27) 0.78 (-0.06, 1.63)
Cord blood hemoglobin 12 Months 3 dose DP -0.03 (-0.21, 0.16) 0.05 (-0.05, 0.19) 0.01 (-0.09, 0.09) 0.02 (-0.14, 0.16) 0.09 (-0.03, 0.28)
Monthly DP -0.02 (-0.16, 0.08) -0.02 (-0.15, 0.04) -0.02 (-0.17, 0.06) 0.03 (-0.07, 0.21) -0.01 (-0.14, 0.07)
24 Months 3 dose DP 0.00 (-0.09, 0.11) -0.04 (-0.19, 0.05) 0.06 (-0.02, 0.16) -0.04 (-0.13, 0.02) 0.01 (-0.10, 0.11)
Monthly DP -0.03 (-0.14, 0.06) -0.04 (-0.20, 0.05) -0.07 (-0.33, 0.09) -0.04 (-0.21, 0.07) -0.04 (-0.25, 0.10)
Child malaria 24 Months 3 dose DP -0.03 (-0.21, 0.16) 0.05 (-0.05, 0.19) 0.01 (-0.09, 0.09) 0.02 (-0.14, 0.16) 0.09 (-0.03, 0.28)
Monthly DP -0.02 (-0.16, 0.08) -0.02 (-0.15, 0.04) -0.02 (-0.17, 0.06) 0.03 (-0.07, 0.21) -0.01 (-0.14, 0.07)
CI, 95% percentile confidence interval from 1000 bootstrap samples; DP, Dihydroartenisinin-piperaquine.
†Includes children who either had a preterm birth, were small for gestation age (<10th percentile), or had a low birth weight
(< 2.5 kilograms).
*Significant i.e. 95% percentile confidence interval excludes the null (zero).
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C.4 Effects of IPTp on child ND outcomes at 12 and 24 months mediated
by any maternal malaria (maternal or placental malaria) (tabular form)
Table C.4 displays results for Figure 4.4 in tabular format.
Table C.4 Indirect effects of any maternal malaria (maternal malaria or placental malaria or both)
on the effect of malaria prophylaxis on child neurodevelopment outcomes at 12 and 24 months
among children whose mothers received either three-dose DP or monthly DP.
ND outcomes 12 months 24 months
Three-dose DP Monthly DP Three-dose DP Monthly DP
Effect (95% CI) Effect (95% CI) Effect (95% CI) Effect (95% CI)
Cognitive ability 0.62 (0.04, 1.27)* -0.32 (-1.06, 0.43) 0.28 (-0.16, 0.78) -0.04 (-0.46, 0.40)
Expressive language 0.13 (-0.36, 0.64) -0.23 (-0.64, 0.15) 0.39 (0.00, 0.83)* -0.08 (-0.47, 0.31)
Receptive language 0.40 (-0.08, 0.95) -0.51 (-1.13, 0.06) 0.55 (0.07, 1.12)* 0.18 (-0.38, 0.79)
Fine motor -0.41 (-1.09, 0.27) -0.02 (-0.80, 0.75) 0.35 (-0.01, 0.75) -0.07 (-0.57, 0.51)
Gross motor 0.16 (-0.53, 0.82) -0.53 (-1.13, 0.06) 0.21 (-0.50, 0.92) -0.16 (-1.05, 0.67)
CI, 95% percentile confidence interval from 1000 bootstrap samples; DP, Dihydroartenisinin
piperaquine; ND, Neurodevelopment.
*Significant i.e. 95% percentile confidence interval excludes the null (zero).
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C.5 Derivation of the mediation effect when
there is one mediator, a mediator-treatment
interaction, and adjusting for child pro-
phylaxis
Assuming Y , M , A, and X are a neurodevelopment outcome, a binary medi-
ator, a binary exposure (IPTp), and child prophylaxis respectively.
E(M |A) = exp(θ0 + θaA)
1 + exp(θ0 + θaA)
E(Y |A,M,X) = β0 + βaA+ βmM + βamAM + βxX
The average causal mediation effect (ACME) or indirect effect is given by,
ACME = E{Y (1,M(1), x)− Y (1,M(0), x)}
= βm
[
exp(θ0 + θa)
1 + exp(θ0 + θa)
− exp(θ0)
1 + exp(θ0)
]
+ βam
[
exp(θ0 + θa)
1 + exp(θ0 + θa)
− exp(θ0)
1 + exp(θ0)
]
C.6 Derivation of the mediation effect with
two mediators
Let Y be a neurodevelopment outcome, M1 be a binary any maternal malaria
(placental or maternal malaria) mediator, M2 be a binary child malaria me-
diator, A be a binary maternal malaria prophylaxis, and X be any covariate
that affects M2 and Y but not M1. The derivation assumes that M1 affects
M2 but not the other way around (Figure C.1). Our analysis involving two
mediators in Chapter 4 does not include X. Then,
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Figure C.1 Directed acyclic graph (DAG) for two mediators.
E(M1|A) = exp(θ0 + θaA)
1 + exp(θ0 + θaA)
E(M2|A,M1, X) = exp(α0 + αaA+ α3M1 + α4X)
1 + exp(α0 + αaA+ α3M1 + α4X)
E(Y |A,M1,M2, X) = β0 + βaA+ β3M1 + β4M2 + β5X
Indirect effects can then be partitioned into indirect effects through only M1,
through only M2, and through both M1 and M2. These effects together with
the direct effect of A to Y have been found to sum to the total effect (Daniel
et al., 2015).
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1. Indirect effect through only M1
IEM1 = E{Y (1,M1(1),M2(0,M1(0), x), x)
− Y (1,M1(0),M2(0,M1(0), x), x)}
= β3
[
exp(θ0 + θa)
1 + exp(θ0 + θa)
− exp(θ0)
1 + exp(θ0)
]
2. Indirect effect through only M2
IEM2 = E{Y (1,M1(1),M2(1,M1(0), x), x)
− Y (1,M1(1),M2(0,M1(0), x), x)}
= β4
 exp(α0 + αa + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)
1 + exp(α0 + αa + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)
−
exp(α0 + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)
1 + exp(α0 + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)

3. Indirect effect through both M1 and M2
IEM1,M2 = E{Y (1,M1(1),M2(1,M1(1), x), x)
− Y (1,M1(1),M2(1,M1(0), x), x)}
= β4
 exp(α0 + αa + α3
(
exp(θ0+θa)
1+exp(θ0+θa)
)
+ α4x)
1 + exp(α0 + αa + α3
(
exp(θ0+θa)
1+exp(θ0+θa)
)
+ α4x)
−
exp(α0 + αa + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)
1 + exp(α0 + αa + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)

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4. Total mediation effect (through M1, M2, and through both M1 and M2).
TME = E{Y (1,M1(1),M2(1,M1(1), x), x)
− Y (1,M1(0),M2(0,M1(0), x), x)}
= β3
[
exp(θ0 + θa)
1 + exp(θ0 + θa)
− exp(θ0)
1 + exp(θ0)
]
+ β4
 exp(α0 + αa + α3
(
exp(θ0+θa)
1+exp(θ0+θa)
)
+ α4x)
1 + exp(α0 + αa + α3
(
exp(θ0+θa)
1+exp(θ0+θa)
)
+ α4x)
−
exp(α0 + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)
1 + exp(α0 + α3
(
exp(θ0)
1+exp(θ0)
)
+ α4x)

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